Lichen simplex chronicus and prurigo

L12_LICHSIMPANDPRURIGO

neurodermatitis: an itchy skin disease similar to atopic dermatitis. It tends to result in focal patches—one or many—that are due to frequent rubbing or scratching of the same area over time.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L28 Cause of death: ICD-10 — L28 2 out of 7 registries used, show all original rules.	2466
4. Check minimum number of events None	2466
5. Include endpoints L12_LICHENSIMPLEX L12_PRURIGONOD L12_PRURIGONAS	2568
6. Filter based on genotype QC (FinnGen only)	2489

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L20-L30
Name in latin: Neurodermatitis

NAME	L12_LICHSIMPANDPRURIGO
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	L12_LICHENSIMPLEX\|L12_PRURIGONOD\|L12_PRURIGONAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L28
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L28
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Lichen simplex chronicus and prurigo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17097	9353	7639
Only index persons	15358	8556	6802
Unadjusted period prevalence (%)
Whole population	0.24	0.27	0.21
Only index persons	0.29	0.31	0.26
Median age at first event (years)
Whole population	56.19	56.86	55.37
Only index persons	55.35	55.98	54.56

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2489	1464	1025
Unadjusted period prevalence (%)	0.50	0.52	0.47
Median age at first event (years)	56.63	55.60	58.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2568: Matched controls
25680

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L29.9

ICD-10 Finland

Pruritus, unspecified

19.5

313.6

250

141

L30.3

ICD-10 Finland

Infective dermatitis

31.9

307.7

307

109

L28.2

ICD-10 Finland

Other prurigo

448.5

307.7

414

D09AB01

ATC

zinc bandage without supplements; topical

72.6

307.7

513

L30.9

ICD-10 Finland

Dermatitis, unspecified

11.0

307.7

1161

1787

D07AC01

ATC

betamethasone; topical

10.2

307.7

1878

5416

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

67.2

307.7

227

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

6.8

307.7

762

1492

D07BC01

ATC

betamethasone and antiseptics; topical

7.2

307.7

752

1395

L28.0

ICD-10 Finland

Lichen simplex chronicus

1650.8

307.7

1261

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

10.9

307.7

720

887

XQ802

NOMESCO Finland

Epicutan test

27.0

307.7

245

100

D07AC13

ATC

mometasone; topical

7.7

307.7

1527

4099

L28.1

ICD-10 Finland

Prurigo nodularis

1776.3

307.7

917

L20.0

ICD-10 Finland

Besnier prurigo

+∞

307.7

376

TQW80

NOMESCO Finland

Local dermatologic skincare

31.7

307.7

342

124

D07AD01

ATC

clobetasol; topical

14.3

307.7

1431

2084

E0000UV, ,

ATC

7.9

307.7

1845

6294

E000001, ,

ATC

6.0

307.7

989

2426

D07AB02

ATC

hydrocortisone butyrate; topical

4.5

305.4

1207

4229

D07AB08

ATC

desonide; topical

6.7

298.1

549

1006

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

271.8

256

L28

ICD-10 Finland

Lichen simplex chronicus and prurigo

32.4

257.0

167

E000002, ,

ATC

5.8

247.3

522

1080

D07CC01

ATC

betamethasone and antibiotics; topical

5.0

240.5

631

1575

D07BA04

ATC

hydrocortisone and antiseptics; topical

5.9

237.3

483

964

L30.0

ICD-10 Finland

Nummular dermatitis

12.5

230.4

235

206

D02AX

ATC

Other emollients and protectives

12.8

209.9

209

176

D02AE01

ATC

carbamide; topical

6.7

209.1

360

607

L29.8

ICD-10 Finland

Other pruritus

25.2

187.0

132

R06AE07

ATC

cetirizine; oral

3.2

177.3

1454

7499

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

5.5

176.0

373

764

A46

ICD-10 Finland

Erysipelas

3.9

169.9

630

1997

E000003, ,

ATC

7.6

156.8

233

333

XQ848

NOMESCO Finland

Dermatological photography

9.3

147.6

183

210

N05BB01

ATC

hydroxyzine; systemic

5.6

146.7

303

603

D07XC01

ATC

betamethasone; topical

3.8

140.1

494

1497

D07AA02

ATC

hydrocortisone; topical

3.8

138.8

492

1496

E000007, ,

ATC

6.4

137.8

242

412

R06AX27

ATC

desloratadine; oral

2.9

136.6

947

4306

H02AB06

ATC

prednisolone; systemic

2.7

133.8

1491

8616

L30.8

ICD-10 Finland

Other specified dermatitis

10.8

121.9

134

130

E000006, ,

ATC

4.8

119.8

290

659

XQ800

NOMESCO Finland

Prick test

4.7

108.7

268

617

L20.8

ICD-10 Finland

Other atopic dermatitis

+∞

97.5

L40.0

ICD-10 Finland

Psoriasis vulgaris

5.3

93.8

196

391

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

+∞

92.2

R06AE09

ATC

levocetirizine; oral

3.0

91.2

490

1892

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.5

90.4

729

3460

L20

ICD-10 Finland

Atopic dermatitis

+∞

87.0

L50.3

ICD-10 Finland

Dermatographic urticaria

9.4

85.9

104

115

D07AC14

ATC

methylprednisolone aceponate; topical

4.8

79.8

191

427

L04AX03

ATC

methotrexate; systemic

3.1

78.6

374

1341

D05BB02

ATC

acitretin; oral

7.0

77.0

119

176

J01DB01

ATC

cefalexin; oral

2.9

76.1

2230

17818

S02

ICPC

Pruritus

5.4

75.7

154

299

L43.0

ICD-10 Finland

Hypertrophic lichen planus

17.8

75.0

J01FF01

ATC

clindamycin; systemic

2.2

73.6

828

4486

L43.9

ICD-10 Finland

Lichen planus, unspecified

6.7

68.4

111

173

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.7

68.1

443

1869

L04AD01

ATC

ciclosporin; systemic

7.3

65.8

139

S97

ICPC

Chronic ulcer skin

3.5

65.7

238

719

D05AX52

ATC

calcipotriol, combinations; topical

3.9

65.2

204

558

S29

ICPC

Skin symptom/complaint other

2.3

63.0

570

2794

L13.0

ICD-10 Finland

Dermatitis herpetiformis

27.3

62.9

J01DA01

ATC

[U] cefalexin

2.0

61.2

1674

12321

D11AH01

ATC

tacrolimus; topical

164.0

61.2

C03CA01

ATC

furosemide; systemic

2.1

61.1

852

4952

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

6.2

61.0

106

177

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

60.8

1280

8600

S87

ICPC

Dermatitis/atopic eczema

7.1

60.8

136

R06AX22

ATC

ebastine; oral

2.4

58.8

508

2433

S76

ICPC

Skin infection other

3.6

58.2

202

592

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

+∞

57.5

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.5

57.4

402

1749

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

4.0

56.9

170

449

69830

ICD-8 Finland

Pruritus and related conditions, Lichenification and lichen simplex chronicus

+∞

56.5

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

15.0

56.3

L43.8

ICD-10 Finland

Other lichen planus

6.1

53.7

158

J04BA02

ATC

dapsone; oral

18.2

53.4

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

51.9

822

4944

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

51.7

408

1869

H02AB04

ATC

methylprednisolone; systemic

2.3

50.2

437

2088

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.7

50.1

169

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

20.8

48.8

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

47.9

537

2838

N02AX02

ATC

tramadol; systemic, rectal

1.8

47.7

1155

7914

R03AC02

ATC

salbutamol; inhalant

1.8

47.2

1430

10476

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.0

46.3

137

359

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

455.6

45.4

S18

ICPC

Laceration/cut

1.8

44.3

1204

8483

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.2

43.9

183

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.7

43.4

105

6983B

ICD-9 Finland

Pruritus and related conditions, Lichenification and lichen simplex chronicus[NEURODERMATITIS CIRCUMSCRIPTA]

+∞

42.8

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

79.9

42.0

R06.0

ICD-10 Finland

Dyspnoea

1.9

41.2

722

4429

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

40.2

535

2991

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.9

39.8

122

328

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.8

39.6

192

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

39.5

394

1978

B86

ICD-10 Finland

Scabies

4.8

39.4

189

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

39.4

1072

7478

R50.9

ICD-10 Finland

Fever, unspecified

2.1

39.2

409

2088

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.6

38.7

208

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

38.7

253

1057

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

38.6

377

1876

N03AX16

ATC

[U] pregabalin

1.9

38.4

635

3812

E000004, ,

ATC

5.8

38.2

123

D07XB05

ATC

dexamethasone; topical

4.5

37.8

216

R06AX13

ATC

loratadine; oral

2.1

37.5

400

2058

H02AB07

ATC

prednisone; oral

2.1

37.4

387

1967

L04AA06

ATC

mycophenolic acid; systemic

5.3

37.4

147

J01CE08

ATC

benzathine benzylpenicillin; parenteral

7.6

37.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

37.0

921

6235

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

36.7

187

688

J01CF05

ATC

flucloxacillin; systemic

2.8

36.1

193

728

L04AX01

ATC

azathioprine; systemic

3.4

36.0

136

420

L73.8

ICD-10 Finland

Other specified follicular disorders

8.5

35.6

TK800

NOMESCO Finland

Hemodialysis

4.6

35.1

191

R60.0

ICD-10 Finland

Localized oedema

2.2

35.1

343

1703

D05AX02

ATC

calcipotriol; topical

3.5

34.9

126

378

SPAT1263

SPAT

Sampling

1.7

34.9

1056

7512

A10AE04

ATC

insulin glargine; parenteral

2.3

34.8

285

1316

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

34.6

308

1473

UJF32

NOMESCO Finland

Coloscopy

1.8

34.5

688

4354

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

9.5

34.5

S21

ICPC

Skin texture symptom/complaint

2.1

34.5

381

1983

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

34.2

335

1664

N06AA12

ATC

doxepin; systemic

2.9

33.7

168

610

ZY010

NOMESCO Finland

Hospital outpatient

3.0

33.6

153

528

A10AB05

ATC

insulin aspart; parenteral

2.5

33.5

226

956

J01MA02

ATC

ciprofloxacin; systemic

1.7

33.3

990

6985

M79.6

ICD-10 Finland

Pain in limb

1.7

33.1

1061

7629

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

33.0

652

4107

L12.0

ICD-10 Finland

Bullous pemphigoid

11.1

32.9

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

32.4

1141

8392

A11CC03

ATC

alfacalcidol; systemic

4.1

32.4

221

I50.9

ICD-10 Finland

Heart failure, unspecified

2.1

32.3

362

1891

L85.3

ICD-10 Finland

Xerosis cutis

7.3

32.2

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

32.2

628

3935

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

32.1

700

4531

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.6

31.6

A02BC02

ATC

pantoprazole; systemic

1.7

31.4

1728

14162

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.2

31.3

308

1530

D11AX14

ATC

[U] tacrolimus

+∞

31.3

L17

ICPC

Foot/toe symptom/complaint

1.7

31.3

730

4810

L29

ICD-10 Finland

Pruritus

6.0

30.8

L08.0

ICD-10 Finland

Pyoderma

8.2

30.8

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

30.5

154

563

R03DC03

ATC

montelukast; oral

1.9

30.3

425

2398

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

30.3

870

6049

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.5

30.1

105

308

N06AX21

ATC

duloxetine; oral

2.1

30.1

322

1651

127

Kela drug reimbursment

Transplant complication

5.2

30.0

122

J01DA09

ATC

[U] cefadroxil

1.7

30.0

671

4362

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

29.9

275

1330

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

305.9

29.9

D07CB01

ATC

triamcinolone and antibiotics; topical

4.5

29.7

166

D01AE15

ATC

terbinafine; topical

2.4

29.2

209

907

G47.3

ICD-10 Finland

Sleep apnoea

1.8

29.2

585

3682

Z94.0

ICD-10 Finland

Kidney transplant status

6.1

28.9

N06AB04

ATC

citalopram; systemic

1.8

28.6

536

3307

E66.8

ICD-10 Finland

Other obesity

2.7

28.4

160

619

L21.0

ICD-10 Finland

Seborrhoea capitis

8.7

28.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.4

28.3

106

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

28.1

348

1878

B35.3

ICD-10 Finland

Tinea pedis

3.0

27.8

129

450

C03DA01

ATC

spironolactone; oral

2.0

27.8

319

1676

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

27.6

373

2074

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.0

27.5

207

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.4

27.2

200

879

P01AB01

ATC

metronidazole; oral, rectal

1.6

27.2

989

7241

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

27.2

438

2578

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

7.0

27.2

D11AH02

ATC

pimecrolimus; topical

+∞

27.1

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

+∞

27.1

N02BE01

ATC

paracetamol; systemic, rectal

2.0

27.1

2256

20209

A10AB04

ATC

insulin lispro; parenteral

3.3

27.0

102

315

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

26.9

237

1124

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

3.3

26.9

102

316

Z3231

NOMESCO Finland

Registered nurse

1.7

26.8

675

4508

I50.0

ICD-10 Finland

Congestive heart failure

2.4

26.8

194

847

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

6.7

26.4

R02

ICPC

Shortness of breath/dyspnoea

2.0

26.3

335

1824

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.6

26.0

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

26.0

552

3518

395

Kela drug reimbursment

Dupilumab

73.4

25.8

N05CF01

ATC

zopiclone; oral

1.6

25.8

805

5664

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

25.7

477

2925

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

94.4

25.7

D06AX01

ATC

fusidic acid; topical

2.2

25.6

242

1181

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

25.5

1742

14635

D07AC03

ATC

desoximetasone; topical

4.6

25.5

136

M54.5

ICD-10 Finland

Low back pain

1.6

25.4

875

6300

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

25.2

294

1551

A10AE05

ATC

insulin detemir; parenteral

2.6

25.2

152

609

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

25.1

655

4404

A10AC01

ATC

insulin (human); parenteral

2.3

25.0

205

943

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

25.0

259

1308

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

25.0

704

4823

K02.1

ICD-10 Finland

Caries of dentine

1.5

24.9

1410

11326

L04AA01

ATC

[U] ciclosporin

5.0

24.9

107

SPAT1262

SPAT

Handing over of treatment supplies

1.8

24.9

445

2696

SPAT1301

SPAT

No procedures

1.6

24.8

756

5279

WW200

NOMESCO Finland

Immunization

3.4

24.8

271

AA1AD

NOMESCO Finland

CT of head and brain

1.6

24.8

678

4610

137

Kela drug reimbursment

Uraemia requiring dialysis

6.5

24.7

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

24.5

601

3973

J01MA12

ATC

levofloxacin; systemic

1.8

24.3

464

2865

N06AX11

ATC

mirtazapine; oral

1.6

24.0

830

5961

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

24.0

419

2518

L50.9

ICD-10 Finland

Urticaria, unspecified

3.1

24.0

101

333

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.9

24.0

116

414

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

23.9

277

1457

SPAT1260

SPAT

Consultation of another employee

1.8

23.9

432

2623

N18.8

ICD-10 Finland

Other chronic renal failure

3.6

23.9

219

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

23.8

562

3673

D11AH05

ATC

dupilumab; topical

68.1

23.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

23.8

723

5037

N03AX12

ATC

[U] gabapentin; oral

1.8

23.7

417

2512

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.8

23.7

122

451

A02BC03

ATC

lansoprazole; oral

1.6

23.5

721

5031

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

23.5

284

1517

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

4.8

23.4

113

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

23.4

218

1057

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

23.3

312

1725

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

23.3

564

3710

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

23.3

766

5433

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

3.2

23.2

288

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

23.2

873

6384

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

23.1

431

2640

T90

ICPC

Diabetes non-insulin dependent

1.6

23.0

590

3938

M79.7

ICD-10 Finland

Fibromyalgia

3.0

23.0

101

342

J01AA02

ATC

doxycycline; systemic

1.6

23.0

1937

16848

J02AC01

ATC

fluconazole; systemic

1.5

22.8

931

6926

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

22.7

1494

12284

R03BA05

ATC

fluticasone; inhalant

1.7

22.7

438

2708

L98.1

ICD-10 Finland

Factitial dermatitis

40.5

22.7

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

232.0

22.7

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

9.4

22.6

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

22.6

163

709

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

22.5

292

1596

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

6.2

22.4

EBA00

NOMESCO Finland

Extraction of tooth

1.5

22.3

847

6194

C07AB07

ATC

bisoprolol; oral

1.5

22.1

1186

9328

N06AX16

ATC

venlafaxine; oral

1.8

22.1

348

2025

B05DA

ATC

Isotonic solutions

6.9

22.1

B05DB

ATC

Hypertonic solutions

7.4

22.1

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.4

22.1

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

22.0

120

457

L26

ICD-10 Finland

Exfoliative dermatitis

+∞

21.9

SFA30

NOMESCO Finland

Three-surface restoration

1.5

21.8

1035

7927

A12AA04

ATC

calcium carbonate; oral

4.4

21.8

124

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

21.7

1573

13138

D07AB01

ATC

clobetasone; topical

3.2

21.7

279

J45

ICD-10 Finland

Asthma

2.0

21.6

251

1320

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

116.0

21.6

V03AE02

ATC

sevelamer; oral

8.8

21.5

SPAT1254

SPAT

Administration of medicine

1.8

21.4

365

2173

K08.3

ICD-10 Finland

Retained dental root

2.2

21.3

197

951

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.8

21.3

179

A06AD11

ATC

lactulose; oral

1.8

21.3

364

2170

Z49.2

ICD-10 Finland

Other dialysis

6.8

21.2

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

21.0

985

7513

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

20.9

187

891

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.1

20.9

217

1096

A02BC05

ATC

esomeprazole; systemic

1.5

20.8

991

7578

SPAT1310

SPAT

Counselling related to known health issue

1.5

20.7

753

5434

A10BA02

ATC

metformin; oral

1.6

20.7

684

4833

S06

ICPC

Rash localized

2.4

20.6

148

643

A02BC01

ATC

omeprazole; systemic

1.6

20.6

662

4646

SPAT1255

SPAT

Intravenous administration of medicine

2.2

20.6

183

870

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

20.4

433

2740

Z2446

NOMESCO Finland

Social worker

2.3

20.4

165

755

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.3

20.3

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.1

20.2

198

978

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

20.2

223

1152

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

48.4

20.2

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.6

20.1

107

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

20.1

183

879

N06AA09

ATC

amitriptyline; systemic

2.0

20.0

248

1333

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

20.0

122

491

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

20.0

198

982

L03.9

ICD-10 Finland

Cellulitis, unspecified

3.7

20.0

173

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

19.9

1313

10677

6983A

ICD-9 Finland

Pruritus and related conditions, Lichenification and lichen simplex chronicus[PRURIGO NODULARIS HYDE]

+∞

19.8

L28

ICPC

Limited function/disability (L)

1.7

19.6

426

2711

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

19.6

183

887

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

19.6

1711

14681

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.9

19.5

S88

ICPC

Dermatitis contact/allergic

4.0

19.5

144

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

19.4

140

610

R53

ICD-10 Finland

Malaise and fatigue

1.6

19.3

551

3753

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.5

19.3

L04AD02

ATC

tacrolimus; systemic

5.1

19.3

R03BB04

ATC

tiotropium bromide; inhalant

1.9

19.2

251

1373

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

19.2

139

606

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

19.1

166

782

N05BA04

ATC

oxazepam; oral

1.6

18.9

619

4349

C08CA13

ATC

lercanidipine; oral

1.7

18.9

358

2195

L40.9

ICD-10 Finland

Psoriasis, unspecified

4.3

18.6

114

R03BA02

ATC

budesonide; inhalant

1.7

18.6

416

2667

S99

ICPC

Skin disease other

3.6

18.5

173

N05AH04

ATC

quetiapine; oral

1.7

18.4

406

2592

TGC00

NOMESCO Finland

Bronchial lavation

3.2

18.4

233

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

18.3

177

869

M25.5

ICD-10 Finland

Pain in joint

1.5

18.3

754

5561

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

18.3

255

1425

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

18.3

1000

7803

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

18.2

258

1449

S01

ICPC

Pain/tenderness of skin

2.4

18.1

123

521

R03BA01

ATC

beclometasone; inhalant

1.7

18.1

336

2046

J01AA07

ATC

tetracycline; systemic

1.7

18.1

334

2031

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

18.1

159

753

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

18.0

365

2276

M04AA01

ATC

allopurinol; systemic

1.8

18.0

306

1817

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

18.0

1104

8797

SPAT1153

SPAT

Removal of sutures

1.5

17.8

754

5585

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

17.8

443

2914

C08CA01

ATC

amlodipine; oral

1.5

17.8

918

7074

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

+∞

17.7

A01AB09

ATC

miconazole; local oral

2.0

17.7

216

1154

R11

ICD-10 Finland

Nausea and vomiting

2.0

17.7

210

1112

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

3.3

17.7

198

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

17.6

324

1968

L43

ICD-10 Finland

Lichen planus

4.4

17.5

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

17.4

197

1026

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

7.1

17.4

R52.2

ICD-10 Finland

Other chronic pain

2.6

17.3

102

404

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

17.3

548

3815

UKC02

NOMESCO Finland

Cystoscopy

1.7

17.2

369

2335

J01FA06

ATC

roxithromycin; oral

1.4

17.1

947

7382

RJ411, ,

NOMESCO Finland

6.9

17.0

J46

ICD-10 Finland

Status asthmaticus

3.0

17.0

266

R06AX18

ATC

acrivastine; oral

2.9

16.9

277

205

Kela drug reimbursment

Chronic hypertension

1.5

16.9

631

4548

L29.0

ICD-10 Finland

Pruritus ani

6.1

16.9

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

16.8

228

1261

N18.0

ICD-10 Finland

End-stage renal disease

4.9

16.8

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

16.8

224

1232

R42

ICD-10 Finland

Dizziness and giddiness

1.6

16.8

534

3714

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.6

16.7

151

SPAT1229

SPAT

Assessment of need for aid

2.0

16.7

190

991

D01AC02

ATC

miconazole; topical

2.0

16.7

188

977

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

+∞

16.7

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

16.7

155

750

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

16.7

115

491

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

16.6

365

SFA10

NOMESCO Finland

One-surface restoration

1.4

16.5

1271

10490

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

7.0

16.5

L03

ICPC

Low back symptom/complaint

1.5

16.5

640

4645

A03

ICPC

Fever

1.7

16.5

360

2288

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

16.4

127

570

N06AB03

ATC

fluoxetine; oral

1.7

16.4

298

1801

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

16.4

669

4907

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

16.3

200

1071

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

16.3

126

566

Z71.8

ICD-10 Finland

Other specified counselling

1.5

16.2

687

5072

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

16.2

896

6961

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

16.2

165

826

J45.8

ICD-10 Finland

Mixed asthma

2.8

16.2

295

M10.9

ICD-10 Finland

Gout, unspecified

2.1

16.2

162

807

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

16.1

427

2845

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

16.1

302

1842

WQ020, ,

NOMESCO Finland

47.8

16.0

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

16.0

204

1106

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

16.0

137

642

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

15.9

602

4341

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.7

15.9

315

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

15.9

376

2437

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

15.9

884

6873

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

15.8

379

2464

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.7

15.7

323

H3603, E103,

ICD-10 Finland

4.9

15.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

15.7

172

886

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.7

15.6

301

P01BA02

ATC

hydroxychloroquine; oral

1.9

15.6

204

1115

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

15.6

166

845

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

15.6

187

993

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

15.6

159

797

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

26.4

15.6

E0001A1, ,

ATC

3.7

15.5

135

SFA20

NOMESCO Finland

Two-surface restoration

1.4

15.5

1356

11393

L30

ICD-10 Finland

Other dermatitis

3.3

15.5

174

L04AA13

ATC

[U] leflunomide

2.9

15.5

258

R51.80

ICD-10 Finland

Headache

1.7

15.5

346

2211

A04

ICPC

Weakness/tiredness general

1.7

15.4

331

2092

K90.0

ICD-10 Finland

Coeliac disease

2.8

15.4

275

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

15.4

416

2783

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

15.3

165

844

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

15.3

1595

13797

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

15.2

101

424

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

15.2

144

702

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

15.1

141

683

WX002

NOMESCO Finland

Sedation and analgesia

1.6

15.1

457

3136

H3601, E103,

ICD-10 Finland

5.3

15.1

R52.9

ICD-10 Finland

Pain, unspecified

1.8

15.1

225

1282

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.7

15.1

295

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

15.1

1046

8433

F34.1

ICD-10 Finland

Dysthymia

2.5

15.1

365

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

5.7

15.1

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

15.1

218

1231

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

15.1

110

482

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

15.0

527

3735

J01FA01

ATC

erythromycin; systemic

1.7

15.0

298

1844

WX290

NOMESCO Finland

Other blockage of nerve

1.4

15.0

1040

8383

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

15.0

620

4547

M48.0

ICD-10 Finland

Spinal stenosis

1.7

14.9

297

1841

A10BH01

ATC

sitagliptin; oral

1.8

14.9

232

1341

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

14.8

259

1548

B01AB05

ATC

enoxaparin; parenteral

1.4

14.8

738

5608

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.9

14.7

108

K07

ICPC

Swollen ankles/oedema

2.3

14.7

116

526

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

14.7

521

3702

T78.4

ICD-10 Finland

Allergy, unspecified

2.5

14.6

395

E66.9

ICD-10 Finland

Obesity, unspecified

2.5

14.6

377

69820

ICD-8 Finland

Pruritus and related conditions, Prurigo

+∞

14.6

B03BA03

ATC

hydroxocobalamin; parenteral

2.1

14.6

134

646

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

14.6

124

580

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

14.5

292

1813

S06.0

ICD-10 Finland

Concussion

1.8

14.5

245

1450

SPAT1151

SPAT

Treatment of major wounds

4.1

14.5

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

14.4

410

2776

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

14.4

109

486

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

14.3

176

942

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.0

14.3

101

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

14.3

336

2172

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

14.3

369

V03AE01

ATC

polystyrene sulfonate; oral

4.1

14.3

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

14.3

670

5028

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

14.2

598

4393

A10AB01

ATC

insulin (human); parenteral

2.5

14.2

346

S91

ICPC

Psoriasis

5.3

14.2

R96

ICPC

Asthma

1.8

14.2

224

1299

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

14.2

297

1864

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

4.0

14.1

102

A28

ICPC

Limited function/disability NOS

1.6

14.1

390

2619

KMAK, ,

NOMESCO Finland

1.4

14.1

1164

9627

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

14.1

166

876

WQ021, ,

NOMESCO Finland

42.7

14.1

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

14.1

361

2382

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

14.1

427

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

14.0

296

1862

J01CA04

ATC

amoxicillin; systemic

1.4

14.0

1951

17609

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

13.9

264

1614

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.2

13.8

116

539

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.7

13.8

243

1453

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

2.5

13.8

363

SPAT1211

SPAT

Application of soft bandage

1.8

13.8

206

1175

L50.8

ICD-10 Finland

Other urticaria

3.5

13.8

132

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

13.7

155

806

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

13.7

235

1397

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

13.6

192

1076

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.8

13.6

243

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

13.6

979

7906

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

+∞

13.6

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.9

13.5

W19

ICD-10 Finland

Unspecified fall

1.8

13.5

222

1303

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

13.5

1195

9973

Z2221

NOMESCO Finland

Medical doctor

1.4

13.4

619

4620

RJ420, ,

NOMESCO Finland

6.1

13.4

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

5.6

13.4

J04AB02

ATC

rifampicin; systemic

3.7

13.4

111

SPAT1216

SPAT

Assessment of functional ability

1.6

13.3

356

2371

SPAT1240

SPAT

Therapeutic discussion

1.8

13.3

220

1293

WZC30

NOMESCO Finland

Teaching

1.6

13.3

363

2430

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

13.3

480

3415

5613

FHL

Conjunctival occlusion

6.3

13.3

N30.0

ICD-10 Finland

Acute cystitis

1.6

13.3

357

2382

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

13.3

282

1776

L29.2

ICD-10 Finland

Pruritus vulvae

4.2

13.2

L15

ICPC

Knee symptom/complaint

1.5

13.2

539

3932

A10BK03

ATC

empagliflozin; oral

1.7

13.1

233

1397

C02AC05

ATC

moxonidine; oral

2.1

13.1

118

565

C09AA02

ATC

enalapril; systemic

1.5

13.1

437

3058

0350X

ICD-9 Finland

Erysipelas[ERYSIPELAS ALIA DEFINITA SEU NUD]

4.8

13.1

A10BJ06

ATC

semaglutide; parenteral

2.1

13.1

123

599

M03BX02

ATC

tizanidine; oral

1.4

13.0

1450

12514

N05AX08

ATC

risperidone; systemic

1.8

13.0

190

1076

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.9

13.0

221

SPAT1284

SPAT

Extensive health certificate

2.7

13.0

249

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

12.9

425

2963

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

19.1

12.9

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.5

12.9

308

L50.0

ICD-10 Finland

Allergic urticaria

2.9

12.9

211

C10AA05

ATC

atorvastatin; oral

1.4

12.8

970

7872

J01AA04

ATC

lymecycline; systemic

1.7

12.8

272

1711

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.9

12.8

Z3226

NOMESCO Finland

Physiotherapist

1.5

12.8

419

2919

A02BA02

ATC

ranitidine; systemic

1.5

12.8

440

3098

B03XA02

ATC

darbepoetin alfa; parenteral

2.9

12.8

212

T89

ICPC

Diabetes insulin dependent

2.3

12.7

427

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.3

12.7

149

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

12.7

222

1325

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.7

12.7

246

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

12.7

102

466

N05BA01

ATC

diazepam; systemic, rectal

1.6

12.7

301

1947

L40.8

ICD-10 Finland

Other psoriasis

5.0

12.6

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

12.6

502

3640

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

12.6

820

6494

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

12.5

204

1193

J01MA14

ATC

moxifloxacin; systemic

1.8

12.5

201

1171

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

12.5

184

1044

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

12.5

157

847

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

+∞

12.5

-1, ,

NOMESCO Finland

1.4

12.5

715

5538

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

12.4

338

2261

J01EA01

ATC

trimethoprim; systemic

1.4

12.3

584

4372

L40

ICD-10 Finland

Psoriasis

3.0

12.3

173

R03AC03

ATC

terbutaline; inhalant

1.6

12.3

306

2004

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

12.2

340

2283

RD210, ,

NOMESCO Finland

3.2

12.2

153

L01BA01

ATC

methotrexate; systemic

2.3

12.1

404

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

12.1

607

4588

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.8

12.1

ZXD05

NOMESCO Finland

Urgent procedure

1.4

12.1

660

5064

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

12.1

150

807

R01AD09

ATC

mometasone; nasal

1.4

12.0

1005

8264

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

12.0

206

1225

D07XB01

ATC

flumetasone; topical

5.0

11.9

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

13.4

11.9

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

11.9

503

3685

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.7

11.9

232

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.6

11.8

111

L84

ICD-10 Finland

Corns and callosities

2.3

11.8

377

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.2

11.8

435

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.9

11.8

R04.0

ICD-10 Finland

Epistaxis

1.8

11.8

172

974

R06AX26

ATC

fexofenadine; oral

1.9

11.7

149

807

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.5

11.7

292

R4110

NOMESCO Finland

Physiotherapy

1.4

11.7

626

4783

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.1

11.7

104

496

D01BA02

ATC

terbinafine; oral

1.4

11.7

567

4259

R05

ICD-10 Finland

Cough

1.5

11.7

465

3366

ZXA05

NOMESCO Finland

Left side

1.4

11.7

559

4189

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

11.6

252

1593

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

11.6

386

S19

ICPC

Skin injury other

2.3

11.6

399

JN4AD

NOMESCO Finland

Body CT examination

1.7

11.6

225

1383

A10AE06

ATC

insulin degludec; parenteral

2.3

11.6

368

R74

ICPC

Upper respiratory infection acute

1.4

11.5

646

4975

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

11.5

151

828

69798

ICD-8 Finland

Lichen, Alius definitus

+∞

11.5

U07

ICPC

Urine symptom/complaint other

1.8

11.5

171

975

R01AD08

ATC

fluticasone; nasal

1.4

11.4

623

4773

K13.29

ICD-10 Finland

Indefinite leukoplakia

3.5

11.4

109

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.7

11.4

RS221, ,

NOMESCO Finland

3.5

11.4

114

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

11.3

571

4314

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

11.3

533

3979

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.0

11.3

118

598

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

11.3

316

EB1VA, ,

NOMESCO Finland

1.6

11.3

272

1766

SPAT1097

SPAT

Recording of ECG

1.5

11.3

327

2216

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.6

11.3

276

1799

V03AE03

ATC

lanthanum carbonate; oral

9.6

11.2

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

11.2

285

1873

XKD00

NOMESCO Finland

Uroflowmetry

1.5

11.2

320

2161

H02AB09

ATC

hydrocortisone; systemic

2.7

11.1

217

L30.4

ICD-10 Finland

Erythema intertrigo

3.9

11.1

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

11.1

401

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

11.0

104

507

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

11.0

169

972

196

Kela drug reimbursment

Paricalcitol and cinacalcet

5.8

11.0

C08CA05

ATC

nifedipine; systemic

1.9

11.0

133

710

R05

ICPC

Cough

1.4

10.9

518

3869

C09CA01

ATC

losartan; oral

1.4

10.9

580

4421

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

10.9

471

3460

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

10.9

153

857

N17

ICPC

Vertigo/dizziness

1.6

10.8

274

1799

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

10.8

829

6700

R06.5

ICD-10 Finland

Mouth breathing

1.7

10.8

201

1221

S02CA02

ATC

flumetasone and antiinfectives; otic

1.9

10.8

126

664

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

10.8

450

3282

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

10.8

139

757

N06AB10

ATC

escitalopram; oral

1.5

10.8

428

3092

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

10.8

244

A08

ICPC

Swelling

2.0

10.7

117

602

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

10.7

220

1372

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.3

10.7

375

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

10.7

128

681

M01AE02

ATC

naproxen; oral, rectal

1.3

10.7

1282

11051

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

10.6

463

3403

D01

ICPC

Abdominal pain/cramps general

1.6

10.5

251

1624

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.2

10.5

125

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

10.5

192

1160

ACC51

NOMESCO Finland

Release of median nerve

1.8

10.5

174

1023

Z00.8

ICD-10 Finland

Other general examinations

1.8

10.5

168

978

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

10.5

120

628

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

10.5

117

607

H03AA01

ATC

levothyroxine sodium; systemic

1.4

10.5

518

3896

ZXE00

NOMESCO Finland

One hour or less

1.3

10.4

869

7101

SPAT1312

SPAT

General health counselling

1.4

10.4

675

5307

R03DC01

ATC

zafirlukast; oral

3.2

10.4

131

69899

ICD-8 Finland

Pruritus and related conditions, Other pruritic conditions

+∞

10.4

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

+∞

10.4

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

10.4

182

1087

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

10.4

392

R13

ICD-10 Finland

Dysphagia

1.8

10.4

157

899

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

10.4

399

K59.0

ICD-10 Finland

Constipation

1.9

10.4

122

645

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

10.4

202

1243

TK810

NOMESCO Finland

Hemofiltration

5.2

10.3

N02BF02

ATC

pregabalin; oral

1.9

10.3

128

689

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

8.2

10.3

OAB50, ,

SPAT

1.9

10.3

132

718

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

10.3

236

1514

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

10.3

113

584

R35

ICD-10 Finland

Polyuria

1.8

10.2

147

829

SPAT1283

SPAT

Restricted health certificate

1.5

10.2

312

2136

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

10.2

489

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

10.2

286

1923

N06AB05

ATC

paroxetine; oral

1.9

10.2

131

714

X58

ICD-10 Finland

Exposure to other specified factors

1.5

10.2

299

2031

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

10.1

213

1336

ZXA10

NOMESCO Finland

Bilateral

1.5

10.1

402

2902

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.5

10.1

246

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

10.1

217

1370

N06AX12

ATC

bupropion; oral

1.9

10.0

135

746

N05CD07

ATC

temazepam; oral

1.6

10.0

252

1652

A10BJ02

ATC

liraglutide; parenteral

2.4

10.0

296

H01

ICPC

Ear pain/earache

1.6

10.0

228

1460

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.0

10.0

493

R06AE08, ,

ATC

4.1

10.0

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

10.0

260

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.8

9.9

173

D11

ICPC

Diarrhoea

1.6

9.9

241

1568

E87.6

ICD-10 Finland

Hypokalaemia

2.2

9.9

381

N17.8

ICD-10 Finland

Other acute renal failure

3.4

9.9

105

N02AA05

ATC

oxycodone; systemic

1.5

9.9

381

2736

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

12.2

9.8

L12

ICPC

Hand/finger symptom/complaint

1.5

9.8

342

2405

N02BF01

ATC

gabapentin; oral

1.7

9.8

187

1143

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

9.8

162

952

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

9.8

175

1051

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

9.8

496

J02AC02

ATC

itraconazole; systemic

1.5

9.8

378

2713

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

9.8

307

2113

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

9.7

186

1138

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

9.7

523

3984

G44.2

ICD-10 Finland

Tension-type headache

1.5

9.7

287

1950

J01XC01

ATC

fusidic acid; systemic

3.4

9.7

101

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.8

9.7

164

C01CA24

ATC

epinephrine; parenteral

1.9

9.7

124

675

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.7

9.6

187

SBA00

NOMESCO Finland

Microbiological examinations

2.4

9.6

258

ZX120

NOMESCO Finland

Intravenous

1.6

9.6

208

1314

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

9.6

671

5327

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

9.6

174

1049

G04BD12

ATC

mirabegron; oral

1.6

9.6

256

1700

A10BB12

ATC

glimepiride; oral

1.8

9.6

147

845

A99

ICPC

Disease/condition unspecnature/site

1.6

9.6

205

1291

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.8

9.6

165

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.9

9.6

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

9.6

482

3631

S08

ICPC

Skin colour change

1.9

9.6

121

656

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

8.4

9.5

SPAT1252

SPAT

Overall medication plan or its review

1.8

9.5

147

847

EBA30

NOMESCO Finland

Extraction of root of tooth

1.8

9.5

135

759

R4120

NOMESCO Finland

Occupational therapy

1.8

9.5

150

871

J05AB01

ATC

aciclovir; systemic

1.4

9.5

465

3486

Z01.2

ICD-10 Finland

Dental examination

1.3

9.5

983

8258

WX320

NOMESCO Finland

Spinalanesthesy

1.4

9.5

538

4135

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

9.5

377

2722

M01AH02

ATC

rofecoxib; oral

1.5

9.5

281

1912

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.0

9.5

496

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.8

9.5

172

ZXA00

NOMESCO Finland

Right side

1.4

9.5

592

4621

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

9.4

462

RS220, ,

NOMESCO Finland

3.3

9.4

103

T78.3

ICD-10 Finland

Angioneurotic oedema

3.3

9.4

103

N06AB06

ATC

sertraline; oral

1.6

9.4

230

1497

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

9.4

590

4605

M01AH01

ATC

celecoxib; oral

1.4

9.4

393

2862

L14

ICPC

Leg/thigh symptom/complaint

1.7

9.4

173

1048

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

9.4

742

5997

N06AX26

ATC

vortioxetine; oral

1.8

9.4

138

784

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

+∞

9.4

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.6

9.3

202

D06

ICPC

Abdominal pain localized other

1.7

9.3

180

1105

WX892

NOMESCO Finland

Monitored bed care

1.7

9.3

165

990

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

9.3

104

541

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

9.3

166

998

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.2

9.3

332

N05AA02

ATC

levomepromazine; systemic

2.1

9.2

432

A10AD01

ATC

insulin (human); parenteral

2.9

9.2

152

B01AF02

ATC

apixaban; oral

1.5

9.2

269

1824

K08.80

ICD-10 Finland

Toothache NOS

1.7

9.2

181

1117

B01AC04

ATC

clopidogrel; oral

1.5

9.2

346

2471

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.3

9.2

289

WX213

NOMESCO Finland

Lower leg blockade

4.2

9.2

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

9.2

142

820

B07.9

ICD-10 Finland

Verruca simplex

2.2

9.2

347

UJD02

NOMESCO Finland

Gastroscopy

1.9

9.2

105

551

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.3

9.2

302

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

4.3

9.1

L08

ICPC

Shoulder symptom/complaint

1.4

9.1

477

3615

L52

ICD-10 Finland

Erythema nodosum

5.0

9.1

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

4.6

9.1

EKA10

NOMESCO Finland

iopsy of buccal mucosa

2.5

9.1

211

L03

ICD-10 Finland

Cellulitis

3.8

9.1

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.8

9.0

165

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

9.1

9.0

L13.9

ICD-10 Finland

Bullous disorder, unspecified

9.1

9.0

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

9.0

347

2488

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

9.0

151

892

L16

ICPC

Ankle symptom/complaint

1.6

9.0

244

1627

U02

ICPC

Urinary frequency/urgency

1.5

9.0

301

2100

E66

ICD-10 Finland

Obesity

1.9

9.0

111

598

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

9.0

150

886

H04AA01

ATC

glucagon; nasal, parenteral

2.7

8.9

183

A10BH05

ATC

linagliptin; oral

1.9

8.9

109

584

E66.0

ICD-10 Finland

Obesity due to excess calories

3.3

8.9

102

N03AX09

ATC

lamotrigine; oral

2.0

8.9

466

P01

ICPC

Feeling anxious/nervous/tense

1.6

8.8

209

1351

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.5

8.8

226

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.3

8.8

276

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

8.7

153

915

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

8.7

480

3664

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

7.2

8.7

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.2

8.7

341

PHD76

NOMESCO Finland

Resection of long saphenous vein

1.9

8.7

109

590

SPAT1360

SPAT

Extensive global examination

1.7

8.7

144

849

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

4.3

8.7

49300

ICD-8 Finland

Asthma, bronchiale

2.5

8.6

216

H3600, E103,

ICD-10 Finland

3.5

8.6

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

8.6

109

591

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.3

8.6

278

XQ845

NOMESCO Finland

Dermatoscopy

2.9

8.6

136

F60.8

ICD-10 Finland

Other specific personality disorders

4.6

8.6

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.6

8.6

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.8

8.6

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

8.6

190

1209

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

8.5

148

883

Z08

ICPC

Social welfare problem

3.2

8.5

105

WX882

NOMESCO Finland

High dependency care

2.3

8.5

280

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

8.5

488

A07EA06

ATC

budesonide; oral, local oral

2.1

8.5

365

PHD99

NOMESCO Finland

Resection of other vein

1.7

8.4

137

802

R01AD58

ATC

fluticasone, combinations; nasal

1.4

8.4

485

3727

NHQ40

NOMESCO Finland

Amputation of toe

2.9

8.4

132

WXQ26

NOMESCO Finland

UVB broad spectrum light therapy

90.4

8.4

WXQ20

NOMESCO Finland

UVA broad spectrum light therapy

90.4

8.4

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

8.4

320

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

8.4

237

1595

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.4

8.4

244

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

8.4

247

1678

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.5

8.4

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

4.5

8.4

P29

ICPC

Psychological sympt/compl other

1.8

8.4

128

737

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

8.3

211

1385

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.3

8.3

276

L01

ICPC

Neck symptom/complaint

1.4

8.3

326

2344

R4190

NOMESCO Finland

Nutritional therapy

2.1

8.3

388

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

8.3

436

A10AA01, ,

ATC

2.4

8.3

245

N03AE01

ATC

clonazepam; systemic

1.8

8.3

123

702

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

8.3

122

695

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

4.1

8.3

L86

ICPC

Back syndrome with radiating pain

1.8

8.2

130

755

R1250

NOMESCO Finland

Evaluation of functional capability

2.4

8.2

221

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.8

8.2

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

8.2

253

1734

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.0

8.2

424

M79.1

ICD-10 Finland

Myalgia

1.5

8.2

296

2095

L71.8

ICD-10 Finland

Other rosacea

3.0

8.2

118

A05

ICPC

Feeling ill

1.8

8.2

114

638

D01AC03

ATC

econazole; topical

1.7

8.2

134

787

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.6

8.2

180

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.9

8.2

509

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

8.1

392

2925

A10AA02, ,

ATC

2.1

8.1

331

A10BK01

ATC

dapagliflozin; oral

1.7

8.1

149

903

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

8.1

950

8064

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

8.1

122

699

SPAT1285

SPAT

Provision of consultation response

1.8

8.1

114

640

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

8.1

175

1107

134

Kela drug reimbursment

General erythroderma

8.1

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

8.1

D05AX03

ATC

calcitriol; topical

3.3

8.1

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.3

8.1

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

11.7

8.1

XCK00

NOMESCO Finland

Perimetry

1.8

8.1

128

745

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

8.1

267

1858

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.1

8.0

346

C10AC01

ATC

colestyramine; oral

2.2

8.0

275

L71.9

ICD-10 Finland

Rosacea, unspecified

2.4

7.9

225

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.4

7.9

219

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

7.9

128

749

P03

ICPC

Feeling depressed

1.6

7.9

173

1097

SPAT1325

SPAT

Vaccination

1.3

7.9

705

5772

R01AD11

ATC

triamcinolone; nasal

1.6

7.9

180

1153

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

7.9

206

1362

J30.3

ICD-10 Finland

Other allergic rhinitis

2.1

7.9

335

WX704

NOMESCO Finland

Intubation

1.6

7.9

172

1090

A07AA09

ATC

vancomycin; oral

3.0

7.9

110

F33.8

ICD-10 Finland

Other recurrent depressive disorders

4.0

7.9

Z00.0

ICD-10 Finland

General medical examination

1.4

7.8

397

2986

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.6

7.8

172

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

7.8

509

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

7.8

517

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.1

7.8

357

C07AB02

ATC

metoprolol; systemic

1.4

7.8

424

3228

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

9.4

7.8

C10AA01

ATC

simvastatin; oral

1.3

7.8

915

7763

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

4.2

7.7

A01

ICPC

Pain general/multiple sites

1.6

7.7

192

1256

QXA70

NOMESCO Finland

Guidance related to rash and skin care

45.1

7.7

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.9

7.7

S01GX02

ATC

levocabastine; ophthalmic

1.8

7.7

112

636

RS222, ,

NOMESCO Finland

3.2

7.7

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

7.7

150

925

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

7.7

120

696

K65.0

ICD-10 Finland

Acute peritonitis

3.3

7.7

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.8

7.6

134

CKC12

NOMESCO Finland

Photocoagulation of retina

1.9

7.6

492

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.3

7.6

261

A07AA02

ATC

nystatin; oral

1.8

7.6

119

690

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.0

7.6

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.1

7.6

320

A01AB04

ATC

amphotericin B; local oral

1.9

7.6

529

L73.9

ICD-10 Finland

Follicular disorder, unspecified

6.7

7.6

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

7.6

230

SPAT1058

SPAT

PEF monitoring instruction

1.6

7.6

169

1078

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.2

7.6

275

R03AC12

ATC

salmeterol; inhalant

1.9

7.5

487

L01

ICD-10 Finland

Impetigo

3.2

7.5

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

7.5

355

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

7.5

106

596

J01FA09

ATC

clarithromycin; systemic

1.3

7.5

665

5433

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

7.5

129

769

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.9

7.5

119

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

7.5

149

924

R03AC13

ATC

formoterol; inhalant

1.8

7.4

106

598

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.6

7.4

159

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.9

7.4

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

7.4

440

SPF40

NOMESCO Finland

Removal and reattachment of crown or small bridge

2.5

7.4

171

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.1

7.4

310

XX9XT

NOMESCO Finland

Other radiological intervention

80.3

7.4

C09AA05

ATC

ramipril; oral

1.3

7.4

533

4231

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

7.4

558

4460

L10

ICPC

Elbow symptom/complaint

1.8

7.4

104

585

J01MA06

ATC

norfloxacin; oral

1.5

7.4

277

1976

207

Kela drug reimbursment

Chronic arrhythmias

1.4

7.3

319

2338

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

8.4

7.3

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

7.3

543

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.3

7.3

234

S10

ICPC

Boil/carbuncle

1.7

7.3

121

714

69240

ICD-8 Finland

Other eczema and dermatitis, Due to other chemicals

+∞

7.3

R52.0

ICD-10 Finland

Acute pain

2.1

7.3

346

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

7.3

286

A41.8

ICD-10 Finland

Other specified sepsis

2.6

7.3

161

M10.0

ICD-10 Finland

Idiopathic gout

2.0

7.3

360

B01AA03

ATC

warfarin; systemic

1.4

7.3

383

2899

SPAT1104

SPAT

Monitoring of emergency patient

1.7

7.3

135

822

WZA00

NOMESCO Finland

Concise certificate

1.7

7.2

133

807

D10

ICPC

Vomiting

1.8

7.2

103

581

R52.1

ICD-10 Finland

Chronic intractable pain

3.4

7.2

SPAT1139

SPAT

Nutrition survey

2.1

7.2

340

I50.1

ICD-10 Finland

Left ventricular failure

1.8

7.2

552

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.0

7.2

105

RJ410, ,

NOMESCO Finland

6.2

7.2

H01.0

ICD-10 Finland

Blepharitis

1.7

7.2

121

716

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.8

7.2

127

M02AA07

ATC

piroxicam; topical

1.3

7.2

786

6590

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.9

7.2

116

P76

ICPC

Depressive disorder

1.7

7.2

122

725

N06AX03

ATC

mianserin; oral

1.8

7.2

103

583

N03AF01

ATC

carbamazepine; oral, rectal

1.8

7.2

103

583

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.1

7.2

328

L29.3

ICD-10 Finland

Anogenital pruritus, unspecified

30.1

7.1

N01

ICPC

Headache

1.5

7.1

201

1352

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

7.1

437

3387

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.5

7.1

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.7

7.1

134

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.7

7.1

134

H57.1

ICD-10 Finland

Ocular pain

2.0

7.1

398

H05BX01

ATC

cinacalcet; oral

3.8

7.1

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

7.0

300

2189

K30

ICD-10 Finland

Functional dyspepsia

1.5

7.0

224

1546

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

8.8

7.0

M07.3

ICD-10 Finland

Other psoriatic arthropathies

3.0

7.0

N19

ICD-10 Finland

Unspecified kidney failure

2.0

7.0

392

R01AD12

ATC

fluticasone furoate; nasal

1.3

7.0

636

5205

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.7

7.0

116

684

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

7.0

358

D51.0

ICD-10 Finland

Vitamin B12deficiency anaemia due to intrinsic factor deficiency

4.2

7.0

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

4.2

7.0

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

7.0

326

2416

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

7.0

428

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.7

7.0

118

700

L88

ICPC

Rheumatoid/seropositive arthritis

1.9

7.0

471

J01DA06

ATC

[U] cefuroxime

1.4

7.0

292

2125

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.0

7.0

359

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.4

7.0

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.3

7.0

220

C08CA02

ATC

felodipine; oral

1.5

6.9

191

1279

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.5

6.9

159

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

6.9

113

665

N02AC04

ATC

dextropropoxyphene; oral

1.9

6.9

402

M01AC06

ATC

meloxicam; systemic, rectal

1.3

6.9

797

6724

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.1

6.9

306

A07EC02

ATC

mesalazine; oral, rectal

1.7

6.8

108

629

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.5

6.8

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

6.8

186

1243

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

6.8

355

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

6.8

425

J01FA10

ATC

azithromycin; systemic

1.2

6.8

1257

11181

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.3

6.8

216

ZXC10

NOMESCO Finland

Use of laser

2.3

6.8

229

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.3

6.8

229

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.1

6.8

288

C07AG02

ATC

carvedilol; oral

1.7

6.8

120

722

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.9

6.8

419

L27.2

ICD-10 Finland

Dermatitis due to ingested food

40.2

6.8

WQ066, ,

NOMESCO Finland

40.2

6.8

S01GX05

ATC

lodoxamide; ophthalmic

2.9

6.7

104

A05AA02

ATC

ursodeoxycholic acid; oral

2.7

6.7

132

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

6.7

102

587

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

6.7

343

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

6.7

131

809

A10AA03, ,

ATC

3.4

6.7

E87.5

ICD-10 Finland

Hyperkalaemia

2.5

6.7

156

S22.3

ICD-10 Finland

Fracture of rib

1.6

6.7

147

935

F61.0

ICD-10 Finland

Mixed personality disorders

2.7

6.7

127

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

6.7

277

2013

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.0

6.7

R4180

NOMESCO Finland

Podiatric therapy

2.8

6.6

116

QXA05

NOMESCO Finland

Skin division, unspecified location

6.4

6.6

F05.9

ICD-10 Finland

Delirium, unspecified

2.3

6.6

200

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

3.1

6.6

N06AG02

ATC

moclobemide; oral

1.8

6.6

495

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

6.6

225

1576

8070/3-C44.7

ICD-O-3

Squamous cell carcinoma, NOS, of skin of lower limb and hip

12.3

6.6

A29

ICPC

General symptom/complaint other

1.4

6.6

257

1847

L73.2

ICD-10 Finland

Hidradenitis suppurativa

3.2

6.6

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

6.6

499

3986

WX402

NOMESCO Finland

General anaesthesia

1.3

6.5

435

3409

SDA03

NOMESCO Finland

Periodontal treatment

1.3

6.5

834

7108

A12BA01

ATC

potassium chloride; oral

1.8

6.5

496

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

1.9

6.5

431

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.1

6.5

292

A10BX07

ATC

[U] liraglutide

2.8

6.5

117

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

3.0

6.5

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.1

6.5

299

Z50.1

ICD-10 Finland

Other physical therapy

1.7

6.5

111

661

RS211, ,

NOMESCO Finland

6.9

6.5

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

6.5

205

1413

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.0

6.5

R03BA08

ATC

ciclesonide; inhalant

1.5

6.5

169

1118

C09CA03

ATC

valsartan; oral

1.5

6.5

194

1323

H60.1

ICD-10 Finland

Cellulitis of external ear

3.1

6.5

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

3.1

6.5

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

6.5

154

999

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.1

6.4

274

R30.0

ICD-10 Finland

Dysuria

1.9

6.4

441

R55

ICD-10 Finland

Syncope and collapse

1.5

6.4

212

1475

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

6.4

522

C09CA06

ATC

candesartan; oral

1.3

6.4

502

4027

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.1

6.4

295

J20

ICD-10 Finland

Acute bronchitis

1.5

6.4

199

1369

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

6.4

110

658

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

6.4

206

1428

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

6.3

568

ND1AE

NOMESCO Finland

Wrist ultrasound examination

6.6

6.3

F43.00

ICD-10 Finland

Acute stress reaction mild

2.2

6.3

223

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

6.3

107

636

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

6.3

379

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

6.3

135

853

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.7

6.3

125

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.2

6.3

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

6.3

561

4574

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

6.3

122

752

T82

ICPC

Obesity

1.9

6.3

408

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

11.0

6.3

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.5

6.3

R12

ICD-10 Finland

Heartburn

1.6

6.3

157

1030

UDC00

NOMESCO Finland

Ear microscopy

1.6

6.3

147

950

ULA02

NOMESCO Finland

Kolposcopy

1.5

6.3

166

1103

J01CA08

ATC

pivmecillinam; oral

1.2

6.3

854

7327

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.7

6.2

120

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

6.2

272

1993

J01DC02

ATC

cefuroxime; systemic

1.7

6.2

107

639

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

6.2

158

1040

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

6.2

820

7008

RJ414, ,

NOMESCO Finland

7.0

6.2

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

6.2

631

5230

EB1WA, ,

NOMESCO Finland

3.7

6.2

T74.1

ICD-10 Finland

Physical abuse

2.5

6.2

144

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.5

6.2

150

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.2

6.2

219

RS121, ,

NOMESCO Finland

4.0

6.2

D69.2

ICD-10 Finland

Other nonthrombocytopenic purpura

6.3

6.2

3025

Kela drug reimbursment

Calcium carbonate

5.3

6.1

SPF20

NOMESCO Finland

Temporary relining of dentures

3.3

6.1

L21

ICD-10 Finland

Seborrhoeic dermatitis

2.6

6.1

127

J05AB11

ATC

valaciclovir; oral

1.4

6.1

280

2068

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

6.1

341

N07BB01

ATC

disulfiram; oral

1.8

6.1

448

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.7

6.1

110

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

2.5

6.1

145

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.8

6.1

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.7

6.1

116

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

6.1

108

651

M86.8

ICD-10 Finland

Other osteomyelitis

12.5

6.1

D01AA02

ATC

natamycin; topical

2.2

6.1

214

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.1

6.1

247

SXC05

NOMESCO Finland

Other oral or dental procedure

1.6

6.1

122

760

PE1AT

NOMESCO Finland

Femoral artery PTA

2.8

6.1

105

S11

ICPC

Skin infection post-traumatic

2.8

6.1

105

L70.0

ICD-10 Finland

Acne vulgaris

2.6

6.0

134

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

6.0

225

1603

AN1

Coronary angiography

1.5

6.0

218

1544

C05AA08

ATC

fluocortolone; rectal, topical

1.4

6.0

282

2092

S17

ICPC

Abrasion/scratch/blister

2.2

6.0

215

NF1DA

NOMESCO Finland

X-ray of hips

2.2

6.0

215

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

1.6

6.0

120

746

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

3.5

6.0

TK820

NOMESCO Finland

Peritoneal dialysis

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

266

63.02

307.65

1.5

16.36

25.21

u/ml

0.66

(40768443) Skin Pathology biopsy report

491

640

9.25

307.65

1.4

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

234

61.20

307.65

1.4

1.5

573.08

96.00

titre

—

(3005322) IgE [Units/volume] in Serum or Plasma

419

1069

4.49

151.04

1.5

1.2

847.13

151.64

u/ml

3.82

398

977

(3006315) Basophils [#/volume] in Blood

1615

10127

2.60

116.06

8.5

5.6

0.04

e9/l

5.12

1485

8671

(3001604) Monocytes [#/volume] in Blood

1609

10102

2.59

114.82

8.6

5.6

0.61

0.58

e9/l

5.21

1480

8658

(3019198) Lymphocytes [#/volume] in Blood

1632

10390

2.57

111.82

8.6

5.7

1.79

1.93

e9/l

3.14

1510

9117

(3013115) Eosinophils [#/volume] in Blood

1644

10504

2.57

111.76

8.8

5.8

0.24

0.19

e9/l

20.28

1522

9122

(40760892) CBC W Ordered Manual Differential panel - Blood

1531

9503

2.51

110.14

8.9

6.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

563

2247

2.93

99.32

2.2

1.7

—

(3019069) Monocytes/100 leukocytes in Blood

1490

9549

2.33

93.68

9.3

6.2

8.66

8.61

0.21

1435

8922

(3006504) Eosinophils/100 leukocytes in Blood

1484

9504

2.33

93.31

9.0

5.9

3.45

2.80

15.30

1427

8865

(3002030) Lymphocytes/100 leukocytes in Blood

1505

9807

2.29

89.23

9.1

6.0

25.69

28.02

14.97

1447

9181

(3022096) Basophils/100 leukocytes in Blood

1441

9226

2.28

89.12

9.0

5.9

0.70

0.67

1.41

1386

8588

(3018010) Neutrophils/100 leukocytes in Blood

1487

9656

2.28

88.71

8.8

5.8

58.47

57.12

4.57

1433

9026

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

835

4313

2.39

85.23

1.4

1.2

2.06

1.50

u/ml

0.59

205

1140

(3013650) Neutrophils [#/volume] in Blood by Automated count

1709

11872

2.31

85.06

11.3

8.9

4.28

4.07

e9/l

3.61

1574

10285

(3007164) IgA [Mass/volume] in Serum or Plasma

755

3760

2.43

83.38

1.6

1.5

2.69

2.44

g/l

1.90

443

2300

(3023368) Bacteria identified in Blood by Culture

947

5460

2.16

71.65

6.1

4.2

—

(3000494) Fungus identified in Specimen by Culture

511

2303

2.52

68.61

1.7

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1333

8903

2.03

66.38

6.0

4.7

35.03

35.56

g/l

2.86

1256

8290

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

879

5094

2.10

64.12

2.7

2.2

3.03

2.96

mg/l

0.39

761

4329

(3013707) Erythrocyte sedimentation rate by Westergren method

1974

15471

2.19

60.48

5.6

4.0

15.21

12.15

mm/h

14.56

1879

14270

(3042936) Bacteria identified in Isolate by Culture

569

2834

2.29

60.27

2.4

2.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2031

16178

2.22

58.45

9.6

7.3

80.84

78.12

u/l

2.13

1941

15217

(3037522) Nuclear Ab [Titer] in Serum

536

2646

2.30

57.72

1.5

1.3

533.87

542.34

titre

0.03

124

548

(3020779) Urea [Moles/volume] in Serum or Plasma

404

1762

2.53

57.38

10.8

7.4

11.25

9.86

mmol/l

2.97

378

1680

(3004588) Protein electrophoresis panel - Serum or Plasma

339

1363

2.71

56.78

2.1

2.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

384

1661

2.54

55.38

2.3

2.8

67.20

66.35

g/l

1.39

353

1506

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1484

10819

1.88

51.70

6.6

6.2

11.06

11.50

umol/l

0.45

1429

10272

(3003458) Phosphate [Moles/volume] in Serum or Plasma

522

2660

2.21

51.47

9.9

5.7

1.10

1.04

mmol/l

4.72

494

2462

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

994

6424

1.89

50.20

3.2

2.5

56.38

70.67

u/l

0.59

919

5901

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1251

8699

1.85

50.07

3.9

2.7

122.41

132.38

ug/l

0.74

1152

8029

(3022948) Iron [Moles/volume] in Serum or Plasma

586

3171

2.10

49.28

3.7

2.4

11.92

13.25

umol/l

4.76

552

2962

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1425

10382

1.84

48.41

10.2

6.5

1.21

mmol/l

3.55

1218

8802

(3004789) Transferrin [Mass/volume] in Serum or Plasma

549

2921

2.12

48.15

3.7

2.4

2.31

2.32

g/l

0.18

514

2711

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

523

2740

2.14

47.71

3.8

2.5

20.72

23.25

3.89

442

2345

(3013826) Glucose [Moles/volume] in Serum or Plasma

1597

12189

1.82

45.11

6.7

4.5

7.11

6.74

mmol/l

6.57

1510

11428

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

947

6248

1.82

43.14

2.5

2.1

204.15

213.38

u/l

0.11

890

5851

(3012095) Magnesium [Moles/volume] in Serum or Plasma

590

3351

1.99

42.67

3.5

3.3

0.80

0.82

mmol/l

2.53

555

3153

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1296

9442

1.75

41.48

9.1

5.8

1.21

mmol/l

1.80

1198

8571

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1191

8493

1.75

40.94

2.2

2.0

93.52

95.09

pmol/l

0.53

639

4336

(36660697) Celiac disease serology panel - Serum

329

1513

2.35

40.81

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

418

2129

2.15

40.44

2.0

1.6

—

(3012516) Albumin [Mass/volume] in Urine

920

6140

1.78

39.48

3.8

3.2

627.49

252.55

mg/l

1.25

634

3848

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

209

786

2.81

39.36

1.9

2.7

3.80

3.60

g/l

1.54

190

710

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

209

787

2.80

39.27

1.9

2.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

209

787

2.80

39.27

1.9

2.7

7.44

7.36

g/l

0.24

190

710

(3036481) Cortisol [Moles/volume] in Serum or Plasma

370

1823

2.20

38.82

2.3

2.0

351.79

374.44

nmol/l

1.28

341

1658

(3026008) Bacteria identified in Urine by Culture

937

6312

1.76

38.77

3.8

3.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1303

9622

1.72

38.74

17.3

15.0

1.24

1.27

inr

0.66

426

2797

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

199

736

2.85

38.66

1.9

2.7

10.44

10.18

g/l

0.38

179

658

(3018418) pH of Serum or Plasma

915

6159

1.75

37.71

6.6

4.0

7.39

7.40

1.13

198

1173

(3027945) Reticulocytes/100 erythrocytes in Blood

426

2241

2.08

37.66

2.6

2.7

1.83

1.80

0.25

380

2005

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1188

8606

1.71

37.47

2.7

2.2

74.26

77.72

nmol/l

4.24

1096

7720

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

197

737

2.81

37.44

1.9

2.7

2.85

2.99

g/l

0.96

178

661

(3037467) Urinalysis macro (dipstick) panel - Urine

1770

14316

1.76

37.00

6.0

4.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

154

511

3.14

36.24

1.5

1.6

0.24

g/l

0.09

144

489

(3020682) Albumin/Creatinine [Ratio] in Urine

944

6477

1.72

35.92

4.4

3.8

16.48

7.89

mg/mmol

2.42

659

4031

(3009508) Creatinine [Moles/volume] in Urine

945

6493

1.72

35.72

3.7

3.2

7.13

7.47

mmol/l

1.58

812

5477

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

427

2295

2.03

35.44

3.2

4.3

239.43

248.58

u/l

0.60

411

2170

(3031040) Bacteria [#/volume] in Urine by Automated count

1696

13633

1.72

35.37

6.0

4.3

3189.33

1723.76

e6/l

0.31

198

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

155

528

3.06

34.86

1.5

1.6

1.22

1.18

g/l

0.86

146

502

(3000850) Epithelial cells [#/volume] in Urine

683

4302

1.80

34.85

3.5

2.5

5.51

5.67

e6/l

0.11

619

3855

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

586

3523

1.86

34.81

1.3

36.87

34.80

iu/ml

0.13

165

1156

(3012544) pH of Venous blood

374

1929

2.10

34.66

5.8

3.7

7.36

7.38

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

528

3084

1.90

34.27

2.1

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

871

5907

1.72

34.18

3.5

3.0

2377.69

1364.24

ng/l

2.37

758

5025

(3019309) Folate [Moles/volume] in Red Blood Cells

618

3797

1.83

34.14

1.8

1.7

1188.40

1175.86

nmol/l

0.12

490

2870

(3026493) Urate [Moles/volume] in Serum or Plasma

808

5390

1.73

33.53

3.3

2.6

4195.98

5424.91

umol/l

0.35

707

4738

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

546

3246

1.87

33.45

2.2

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

180

685

2.75

33.06

1.3

2.09

0.89

u/ml

0.26

(3021589) Normoblasts [#/volume] in Blood

1226

9154

1.65

32.98

14.7

9.1

0.00

e9/l

0.88

1060

7442

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

299

1441

2.22

32.87

1.8

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

303

1472

2.20

32.64

2.8

2.7

10.75

10.55

g/l

0.29

273

1340

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

176

673

2.73

32.02

2.1

2.7

0.48

1.10

g/l

2.25

153

586

(3021960) Folate [Moles/volume] in Serum or Plasma

731

4794

1.73

31.97

1.7

1.5

20.26

20.85

nmol/l

0.51

644

4085

(3023520) Reticulocytes [#/volume] in Blood

330

1676

2.11

31.70

2.6

2.7

70.41

69.69

e9/l

0.15

255

1258

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

154

554

2.89

31.42

1.9

2.7

0.00

g/l

-0.00

140

512

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

153

550

2.89

31.25

1.9

2.7

0.00

g/l

-0.00

140

512

(3002032) Base excess in Venous blood by calculation

354

1864

2.04

30.82

6.6

3.7

1.62

2.04

mmol/l

1.24

308

1545

(3021447) Carbon dioxide [Partial pressure] in Venous blood

355

1872

2.04

30.78

5.9

3.7

5.85

5.84

kpa

0.06

349

1811

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

159

591

2.80

30.52

1.9

2.7

0.01

0.02

g/l

0.28

145

546

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

312

1577

2.11

30.29

5.3

3.7

116.73

88.98

ng/l

3.40

273

1363

(3028026) IgM [Mass/volume] in Serum or Plasma

249

1150

2.29

30.25

2.0

1.8

1.28

1.32

g/l

0.12

223

1048

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1907

16114

1.71

30.14

4.7

3.9

14.76

14.79

pmol/l

0.24

1776

14630

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

163

622

2.73

29.76

1.8

2.6

37.99

37.80

g/l

0.16

144

545

(3002582) Erythrocytes [#/volume] in Urine

886

6224

1.65

29.40

4.3

3.2

85.03

95.12

e6/l

0.08

722

4761

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

448

2620

1.86

28.46

1.9

1.6

—

(3018095) Leukocytes [#/volume] in Urine

998

7291

1.60

27.85

4.9

3.6

100.75

106.90

e6/l

0.07

758

5110

(3014111) Lactate [Moles/volume] in Serum or Plasma

334

1784

2.00

27.79

8.8

7.0

1.39

1.37

mmol/l

0.07

326

1739

(3026782) Osmolality of Urine

628

4094

1.71

27.40

3.8

2.8

516.81

544.19

mosm/kgh2o

2.54

552

3518

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

402

2302

1.88

27.19

2.5

2.7

6.98

8.05

umol/l

0.63

342

2013

(40758558) Short blood count panel - Blood

762

5240

1.65

27.04

8.0

6.6

—

(3009261) Glucose [Presence] in Urine by Test strip

1305

10245

1.56

26.06

4.7

3.6

0.04

0.00

estimate

0.93

255

1811

(3021601) Nitrite [Presence] in Urine by Test strip

1291

10114

1.56

26.00

6.3

4.8

0.00

estimate

0.50

280

1853

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2319

21036

2.06

25.91

23.4

13.6

24.15

23.76

mg/l

0.21

2014

16513

(3017181) Myelocytes/100 leukocytes in Blood

314

1688

1.98

25.55

4.6

4.0

0.59

0.93

2.83

127

570

(3035350) Ketones [Presence] in Urine by Test strip

1291

10138

1.55

25.55

4.7

3.6

0.00

estimate

0.16

290

1985

(3002179) Metamyelocytes/100 leukocytes in Blood

291

1525

2.02

25.45

4.3

3.8

0.57

0.73

0.83

114

487

(36304419) Bacteria [Presence] in Urine

788

5558

1.60

24.80

4.2

3.0

—

(3030467) Casts [#/volume] in Urine by Automated count

803

5697

1.60

24.63

4.3

3.0

0.41

0.47

e6/l

0.30

646

4318

(3000991) Gas panel - Venous blood

310

1680

1.96

24.61

11.4

8.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

530

3387

1.71

24.54

1.3

1.2

11.63

12.83

u/ml

0.13

203

1332

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

377

2182

1.85

24.49

4.8

3.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

385

2248

1.84

24.30

2.0

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

142

4.38

24.16

1.7

2.1

11.70

5.86

umol/l

1.17

(3015736) pH of Urine

1068

8121

1.54

23.95

4.0

3.3

5.87

5.86

0.02

583

(3021440) Promyelocytes/100 leukocytes in Blood

297

1604

1.96

23.78

4.7

4.0

0.07

0.12

0.90

110

486

(3012494) Peanut IgE Ab [Units/volume] in Serum

8.88

23.31

1.0

1.1

4.14

0.23

u/ml

0.59

(3048689) Calprotectin [Mass/mass] in Stool

398

2378

1.80

23.22

2.3

2.2

132.38

135.62

ug/g

0.08

321

1898

(3015377) Calcium [Moles/volume] in Serum or Plasma

953

7107

1.54

23.14

3.5

3.4

2.35

mmol/l

1.44

854

6256

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

145

592

2.54

23.09

1.7

1.6

0.14

10.31

iu/ml

0.50

118

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

177

795

2.32

22.85

1.9

2.0

2.22

2.32

ug/l

0.05

159

705

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

379

2247

1.81

22.65

2.0

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

133

527

2.61

22.53

1.1

8.78

4.74

u/ml

0.32

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

185

852

2.26

22.51

1.8

1.9

39.11

38.96

u/l

0.03

160

755

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

914

6792

1.54

22.36

3.7

3.2

32.57

35.67

u/l

0.58

858

6437

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2158

19335

1.73

22.29

5.8

4.7

1.90

2.09

mu/l

0.87

2030

17668

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

107

381

2.89

22.25

1.7

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

108

389

2.85

21.99

1.7

1.4

31.82

18.45

u/ml

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

575

3860

1.63

21.72

2.7

3.0

2.45

mmol/l

0.15

498

3407

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

6.74

21.69

1.9

1.5

9.21

8.29

ug/l

0.66

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

308

1738

1.88

21.53

2.9

2.8

221.02

191.14

ng/l

0.45

281

1575

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

171

778

2.28

21.41

1.1

2.54

1.72

u/ml

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1022

7844

1.50

21.14

4.5

3.5

43.61

108.08

ng/l

0.56

727

5384

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

149

649

2.38

20.63

1.6

96.00

344.80

titre

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2356

21777

1.99

20.60

25.9

15.7

139.23

139.74

mmol/l

17.04

2317

21218

(3027801) Oxygen [Partial pressure] in Arterial blood

386

2363

1.75

20.55

8.6

7.2

11.43

12.46

kpa

3.16

363

2250

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

386

2363

1.75

20.55

8.6

7.2

5.11

5.10

kpa

0.02

365

2252

(3023103) Potassium [Moles/volume] in Serum or Plasma

2360

21845

1.99

20.26

26.2

15.8

3.99

3.97

mmol/l

3.47

2318

21254

(3003396) Base excess in Arterial blood by calculation

384

2356

1.74

20.26

8.5

7.2

0.79

1.10

mmol/l

0.68

299

1856

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

353

2.85

19.97

1.8

1.4

111.08

123.86

u/ml

0.44

(3025159) Blasts/100 leukocytes in Blood

273

1520

1.89

19.83

4.8

4.1

0.24

0.10

0.27

411

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

642

4516

1.56

19.63

1.8

1.29

1.23

mg/l

0.14

508

3462

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

588

4055

1.58

19.60

4.3

3.6

438.23

407.37

ng/l

0.07

451

3164

(3016502) Oxygen saturation in Arterial blood

347

2108

1.75

18.89

8.8

7.6

94.77

95.60

1.45

331

2025

(3018677) aPTT in Platelet poor plasma by Coagulation assay

473

3122

1.63

18.83

2.1

29.82

29.76

0.09

463

3035

(3003888) Timothy IgE Ab [Units/volume] in Serum

266

3.07

18.81

1.1

5.75

5.11

u/ml

0.09

126

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

102

390

2.68

18.57

7.9

5.6

252.47

794.30

iu/ml

0.86

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

326

1956

1.76

18.51

2.4

2.1

0.21

g/l

0.41

298

1834

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2151

19498

1.64

18.34

7.5

5.6

41.87

39.80

mmol/mol

14.23

2018

18029

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

997

7782

1.46

18.15

5.0

3.7

—

(40768797) Stomach Pathology biopsy report

441

2885

1.64

18.14

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

131

571

2.36

18.12

2.2

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

122

515

2.44

18.12

1.7

2.0

11.62

11.00

mg/l

0.28

113

469

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

322

2.83

18.01

1.3

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

260

3.02

17.64

1.1

0.60

1.13

u/ml

0.51

103

(3020874) Milk IgE Ab [Units/volume] in Serum

4.93

17.57

1.1

0.52

1.33

u/ml

0.37

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

143

660

2.24

17.31

2.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

125

550

2.34

16.93

4.1

3.2

1.82

1.55

mg/l

2.20

117

504

(40767503) Oxygen content in Capillary blood by calculation

105

427

2.52

16.90

3.5

2.3

16.08

16.30

0.19

212

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

314

2.77

16.57

1.1

3.57

1.83

u/ml

0.39

160

(3011397) Hemoglobin [Presence] in Urine by Test strip

654

4785

1.49

16.16

4.3

3.5

—

(3034770) Mitochondria Ab [Titer] in Serum

124

555

2.30

16.16

1.2

784.00

1273.75

titre

—

(3044889) 12 lead EKG panel

1717

14988

1.44

16.09

4.5

3.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

102

419

2.49

16.08

2.9

29.83

37.40

umol/l

1.89

378

(3021879) Hepatitis B virus core Ab [Presence] in Serum

242

1387

1.82

15.96

1.6

1.4

—

(3037756) Immunofixation for Serum or Plasma

398

2.52

15.83

1.5

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

382

2.54

15.67

1.8

1.7

—

(3024928) Oxygen saturation in Venous blood

105

443

2.43

15.64

6.1

2.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

174

901

2.00

15.61

1.7

1.8

1.66

1.53

g/l

1.07

144

786

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

615

4487

1.49

15.28

1.8

1.7

16179790.22

32745214.60

pmol/l

0.44

513

3738

(3029937) Albumin [Presence] in Urine by Test strip

724

5455

1.46

15.26

5.5

3.9

0.00

estimate

1.08

263

1796

(3026389) Candida sp identified in Specimen by Organism specific culture

260

2.86

15.25

1.7

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

180

951

1.96

15.24

5.0

2.5

0.65

0.08

180

945

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

115

513

2.30

15.11

1.3

1.2

26.41

40.08

u/ml

—

(3003327) Ova and parasites identified in Stool by Light microscopy

127

594

2.20

14.90

1.9

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1591

13792

1.40

14.84

4.0

3.0

56.07

48.99

u/l

2.50

1484

12826

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

120

550

2.24

14.80

1.5

1.7

—

(4200892) Spirometry reversibility

244

1435

1.77

14.74

1.5

1.4

—

(3042733) HLA Ab [Presence] in Serum

4.90

14.74

6.0

5.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

109

481

2.32

14.70

1.9

1.6

12267.74

13809.88

e6/l

0.17

360

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

120

555

2.22

14.48

1.4

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

310

1959

1.66

14.42

9.8

7.9

119.69

121.63

g/l

0.89

299

1897

(3025941) Bacteria identified in Stool by Culture

200

1116

1.86

14.36

1.4

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

496

3506

1.51

14.26

3.2

2.7

0.82

1.20

e6/l

1.97

278

1984

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

180

973

1.91

14.25

5.0

2.6

1.36

1.19

0.94

180

968

(3027135) IgG subclass 1 [Mass/volume] in Serum

169

3.24

14.11

1.1

1.5

7.36

6.79

g/l

0.41

119

(3010726) Horse dander IgE Ab [Units/volume] in Serum

239

2.85

13.98

1.1

1.44

0.80

u/ml

0.58

112

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

106

473

2.29

13.94

1.3

1.2

3.50

8.60

u/ml

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1185

9845

1.38

13.91

3.0

2.5

—

(3021788) Differential panel - Synovial fluid

352

2.49

13.70

1.8

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

106

478

2.27

13.61

1.3

1.2

3.03

7.56

u/ml

0.97

(3024471) HLA-A [Type]

4.67

13.53

1.0

—

(3019060) Gas panel - Arterial blood

227

1341

1.76

13.49

5.1

4.7

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

169

3.18

13.44

1.1

1.5

2.80

3.03

g/l

0.46

121

(3024139) IgG subclass 3 [Mass/volume] in Serum

169

3.18

13.44

1.1

1.5

0.46

0.40

g/l

0.47

121

(3007566) Smooth muscle Ab [Titer] in Serum

117

554

2.16

13.34

1.2

106.36

93.04

titre

0.15

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

369

2.43

13.32

1.4

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

694

5301

1.42

13.25

5.1

3.8

91.40

90.16

0.64

673

5166

(3052851) Hemolysis interference index of Serum or Plasma

129

637

2.08

13.20

2.9

3.2

—

(4062490) Immunoglobulin typing, IgG

171

3.14

13.19

1.1

1.5

—

(1616796) Gas panel - Central venous blood

102

459

2.27

13.17

6.2

3.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

203

2.95

13.16

1.2

51.37

65.79

u/l

1.39

185

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

323

2.52

13.13

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

114

539

2.17

13.05

1.8

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

215

2.88

13.03

2.0

2.3

0.71

1.28

g/24h

1.74

101

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

191

1085

1.82

12.95

10.3

9.6

24.00

24.31

mmol/l

0.60

184

1058

(40768446) Kidney Pathology biopsy report

4.37

12.87

1.7

—

(3024932) HLA-DR beta [Type]

4.59

12.82

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2209

20533

1.54

12.76

5.5

4.5

6.19

5.95

mmol/l

9.18

2030

18680

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

352

2.43

12.75

1.5

1.2

277.05

268.46

u/ml

0.09

216

(3014599) Egg white IgE Ab [Units/volume] in Serum

4.22

12.70

1.1

1.0

0.65

0.48

u/ml

—

(3010375) cycloSPORINE [Mass/volume] in Blood

4.17

12.50

32.1

23.7

94.67

123.30

ug/l

1.66

(3024980) IgG subclass 4 [Mass/volume] in Serum

290

2.56

12.41

1.2

1.7

0.90

0.83

g/l

0.20

224

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

725

5635

1.40

12.38

1.9

1.6

1.50

1.37

mmol/l

2.93

618

4683

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.71

12.35

1.3

1.1

—

(3003181) Sodium [Moles/volume] in Urine

340

2.43

12.26

1.3

63.23

62.74

mmol/l

0.04

271

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

125

628

2.04

12.22

2.9

3.9

43.20

71.96

mg/l

0.72

514

(3034860) Kappa light chains.free [Mass/volume] in Serum

125

628

2.04

12.22

2.9

3.9

49.03

65.68

mg/l

0.69

516

(3002385) Erythrocyte distribution width [Ratio]

1992

18187

1.42

12.21

26.4

16.3

15.07

14.97

0.33

1979

17827

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

398

2.31

12.12

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

398

2.31

12.12

1.4

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

336

2.43

12.10

1.7

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

119

3.49

12.09

1.6

6.32

6.36

u/l

0.01

103

(40760888) Immunoglobulin light chains.free panel - Serum

100

465

2.20

11.95

3.2

4.1

—

(3012501) Base excess in Blood by calculation

100

465

2.20

11.95

7.5

4.2

3.03

2.53

mmol/l

1.03

320

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

192

1119

1.77

11.95

11.0

9.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

363

2.36

11.93

6.4

3.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

345

2.39

11.88

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

402

2.28

11.85

5.0

3.4

59.42

56.97

1.08

402

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

102

480

2.17

11.84

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

212

1276

1.72

11.79

4.9

3.5

5.20

5.16

kpa

0.28

203

1215

(3022145) Colonoscopy Study observation

339

2295

1.55

11.75

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

304

2.48

11.75

1.4

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

449

2.21

11.73

2.4

2.1

128.08

130.55

g/l

0.42

325

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

9.66

11.72

12.1

10.8

4.83

5.67

mmol/l

0.76

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

134

701

1.96

11.71

2.2

2.3

543.23

469.69

ug/l

0.14

126

653

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

263

2.59

11.69

1.3

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

269

2.57

11.68

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

456

3290

1.47

11.64

3.4

2.9

2.64

2.43

e6/l

0.22

237

1773

(3019150) Specific gravity of Urine by Refractometry

588

4448

1.42

11.63

4.8

3.9

1.02

kg/l

0.44

653

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.68

11.41

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

110

541

2.08

11.41

1.4

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

120

610

2.01

11.38

2.7

3.9

0.97

2.56

ratio

—

(3021901) Oxygen saturation in Capillary blood

367

2.30

11.21

3.9

2.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

201

1209

1.72

11.20

4.8

3.5

2.03

1.81

mmol/l

0.34

151

888

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

132

698

1.94

11.19

2.9

3.3

0.31

0.36

u/ml

0.91

393

(3041096) Erythrocytes [Presence] in Urine by Automated

697

5459

1.38

11.17

4.5

3.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

466

2.15

11.10

1.7

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

116

3.40

11.10

1.3

1.1

87.84

85.09

u/l

0.08

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

111

554

2.05

11.08

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

196

1176

1.72

11.02

1.6

1.4

—

(3009343) pH of Capillary blood

207

1261

1.70

11.01

4.9

3.5

7.41

0.01

154

(3000570) Elastase.pancreatic [Mass/mass] in Stool

116

593

2.00

10.84

1.4

272.74

289.70

ug/g

0.40

341

(3019420) Tryptase [Mass/volume] in Serum or Plasma

3.91

10.84

1.2

1.8

12.60

10.00

ug/l

0.27

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

268

2.50

10.76

1.1

5.14

3.00

u/ml

0.76

127

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

239

2.59

10.71

1.8

1.5

56.57

58.15

0.10

149

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1460

12823

1.32

10.58

3.1

2.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

455

2.13

10.58

3.8

3.0

8.23

8.16

kpa

0.18

441

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

273

1801

1.58

10.57

2.5

2.3

6.70

7.29

ug/l

0.15

243

1593

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

262

1713

1.59

10.54

6.6

3.5

1.21

1.23

mmol/l

3.05

234

1489

(3044941) Cell count panel - Synovial fluid

314

2.36

10.52

1.6

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.50

10.48

1.5

1.3

—

(3010421) pH of Blood

110

560

2.01

10.41

7.6

3.9

7.41

7.42

0.47

101

501

(40768804) Tissue Pathology biopsy report

1012

8473

1.32

10.21

2.2

2.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2229

20951

1.48

10.21

5.2

4.4

4.60

4.69

mmol/l

4.42

2081

19441

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2214

20792

1.47

10.09

5.1

4.4

1.41

1.47

mmol/l

11.24

2053

19180

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2363

22515

1.62

9.92

15.3

10.1

26.13

26.33

u/l

0.24

2301

21711

(3000492) Spirometry study

291

1983

1.53

9.73

1.6

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2260

21340

1.49

9.71

5.7

4.9

2.70

2.78

mmol/l

3.45

2100

19677

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

437

2.10

9.70

1.6

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

147

846

1.78

9.58

5.0

4.9

1.72

1.63

0.45

135

781

(3014148) Varicella zoster virus Ab [Titer] in Serum

218

2.56

9.47

1.1

1.2

—

(3037121) Protein [Mass/volume] in Urine

129

716

1.84

9.47

2.9

3.1

0.27

0.29

g/l

0.13

287

(3016038) Potassium [Moles/volume] in Urine

129

3.05

9.39

1.1

1.2

24.50

35.56

mmol/l

3.21

113

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

114

3.19

9.32

1.3

1.1

14.97

19.99

u/l

0.41

(3019832) Treponema pallidum Ab [Presence] in Serum

219

1413

1.60

9.31

1.8

1.6

—

(3044927) Protein electrophoresis panel - Urine

215

2.54

9.22

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

228

2.49

9.13

1.4

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

193

2.62

9.09

1.6

1.3

143443.63

107166.36

e6/l

0.11

130

(3015235) Bicarbonate [Moles/volume] in Capillary blood

101

525

1.96

9.05

4.1

3.0

24.90

24.78

mmol/l

0.10

101

512

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

436

3257

1.41

9.04

1.6

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.73

8.88

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

240

2.41

8.67

1.1

—

(40761511) CBC panel - Blood by Automated count

2306

21954

1.49

8.56

21.0

12.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2139

20091

1.39

8.56

4.7

3.9

1.42

1.30

mmol/l

10.82

1972

18379

(3007930) Methemoglobin/Hemoglobin.total in Blood

142

837

1.74

8.55

5.1

4.9

0.87

0.90

0.39

131

774

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

267

2.32

8.51

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

280

1946

1.49

8.51

3.2

2.2

31.48

63.95

u/l

0.74

241

1682

(40761535) Cells panel - Urine sediment

246

1665

1.53

8.48

4.1

3.2

—

(3028433) Virus identified in Specimen by Culture

4.18

8.45

1.4

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

242

1634

1.53

8.43

2.8

2.6

60.52

66.46

ml/min/173m2

1.41

116

632

(3044640) Blood type and Crossmatch panel - Blood

801

6629

1.30

8.38

2.8

2.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

148

892

1.70

8.23

4.6

3.6

44.68

48.58

1.03

148

877

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

4.55

8.12

1.1

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

433

2.00

8.10

3.4

1.9

0.95

0.82

nmol/l

0.97

360

(3002079) Sodium [Moles/time] in 24 hour Urine

3.40

8.07

1.3

159.05

165.13

mmol/24h

0.12

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

332

2.14

8.07

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

188

2.53

7.99

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

492

1.92

7.96

2.5

2.3

188.09

103.33

ug/min

0.46

305

(3016650) Hepatitis A virus Ab [Presence] in Serum

328

2.13

7.92

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

189

2.51

7.91

2.2

3.3

60.05

57.58

0.35

161

(3047181) Lactate [Moles/volume] in Blood

115

654

1.79

7.85

5.8

1.32

1.33

mmol/l

0.02

564

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

357

2.08

7.79

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

204

2.43

7.67

1.1

1.0

3.75

1.99

u/ml

0.51

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

123

2.87

7.64

1.3

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

193

1269

1.56

7.59

3.5

3.3

4.41

4.47

pmol/l

0.39

172

1124

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

8.04

7.59

1.1

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

10.05

7.53

1.0

—

(3011412) CD3 cells [#/volume] in Blood

164

2.59

7.52

2.1

1.18

1.11

e9/l

0.22

150

(3012565) Volume of 24 hour Urine

103

3.03

7.46

1.9

2.7

1892.56

1915.33

0.04

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

468

1.91

7.44

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

126

2.80

7.32

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

197

2.41

7.27

2.5

2.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

185

2.46

7.26

1.1

4.54

3.80

u/ml

0.10

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

216

2.34

7.24

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

321

2.08

7.17

3.0

3.4

0.97

1.58

1.38

282

(3020891) Body temperature

131

795

1.68

7.14

5.5

4.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

193

1287

1.54

7.14

9.1

6.7

24.50

24.57

mmol/l

0.09

178

1213

(3009542) Hematocrit [Volume Fraction] of Blood

2424

23449

1.60

7.00

34.2

20.1

39.48

40.11

4.43

2241

21934

(3015076) Soybean IgE Ab [Units/volume] in Serum

3.40

6.97

1.1

1.0

0.29

0.15

u/ml

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

333

2.04

6.89

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

333

2.04

6.89

1.6

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

13.80

6.89

5.8

3.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

382

1.96

6.85

1.3

1.2

47.57

46.69

u/ml

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.45

6.84

2.9

1.9

130.75

162.96

umol/l

0.21

(3000012) Reticulocyte production index

274

2.14

6.81

2.3

2.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

185

2.40

6.78

1.4

1.3

21.32

33.56

1.72

112

(3035941) MCH [Entitic mass]

2425

23478

1.59

6.76

33.6

20.0

30.27

30.32

0.74

2405

23131

(3024731) MCV [Entitic volume]

2425

23478

1.59

6.76

33.7

20.0

91.28

91.10

1.03

2406

23135

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

3.64

6.75

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

320

2379

1.39

6.75

1.9

1.8

1.63

1.48

2.10

273

2072

(3007461) Platelets [#/volume] in Blood

2424

23468

1.59

6.74

33.9

20.1

256.94

250.67

e9/l

4.53

2390

22858

(3010813) Leukocytes [#/volume] in Blood

2425

23480

1.59

6.74

33.8

20.1

6.97

6.65

e9/l

11.29

2385

22791

(3026361) Erythrocytes [#/volume] in Blood

2425

23480

1.59

6.74

33.8

20.0

4.42

4.49

e12/l

7.40

2383

22799

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

618

5076

1.29

6.59

2.9

2.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

2425

23491

1.58

6.59

34.0

20.2

132.91

135.31

g/l

11.70

2406

23143

(3030981) Hyaline casts [#/volume] in Urine by Automated count

161

1050

1.57

6.59

2.9

2.8

0.27

0.32

e6/l

0.17

156

1024

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

111

2.81

6.58

2.0

2.2

592.48

470.28

e6/l

0.59

(40759836) Histone Ab [Presence] in Serum by Immunoblot

140

2.59

6.54

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

140

2.59

6.54

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

140

2.59

6.54

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

4.07

6.35

33.1

6.3

—

(3042631) Mycobacterium sp identified in Specimen

262

2.12

6.35

3.3

2.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

108

2.80

6.32

1.3

1.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

143

2.54

6.28

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

143

2.54

6.28

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

143

2.54

6.28

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

155

2.47

6.27

1.4

1.6

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

+∞

6.25

1.0

0.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

179

1210

1.52

6.24

1.9

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

132

833

1.62

6.21

2.5

1.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

212

2.24

6.21

3.4

4.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.28

6.16

1.3

2.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2108

19992

1.30

6.10

20.8

12.8

78.88

80.51

ml/min/173m2

2.32

1789

16550

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

196

1357

1.48

6.09

1.2

108.92

157.13

iu/ml

1.14

493

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.77

6.08

31.3

6.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

122

2.64

6.06

2.4

1.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

209

2.22

5.98

1.8

1.6

—

(3017704) Immunofixation for Urine

123

2.62

5.97

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

589

1.71

5.86

1.4

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

173

2.33

5.84

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

173

2.33

5.84

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

173

2.33

5.84

1.6

1.5

—

(3008295) Osmolality of Serum or Plasma

206

2.21

5.76

1.4

1.3

271.91

279.72

mosm/kgh2o

1.41

165

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

563

1.71

5.71

1.9

2.6

211.86

192.20

1.18

540

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

109

2.68

5.66

1.3

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

588

1.69

5.64

1.4

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

295

2230

1.36

5.61

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

120

760

1.61

5.60

2.3

1.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

10.03

5.53

2.1

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

10.03

5.53

2.4

3.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

191

2.22

5.48

1.9

1.6

—

(3011648) Oxygen content in Venous blood

179

2.25

5.42

3.2

2.0

10.06

11.06

0.71

179

(42529406) Shigella sp [Presence] in Stool by Culture

595

1.67

5.41

1.4

1.2

—

(3008898) HLA-B27 [Presence]

105

651

1.64

5.35

1.2

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

174

2.26

5.33

1.1

1.0

0.21

0.06

u/ml

0.73

(3017732) Neutrophils [#/volume] in Blood

197

1409

1.43

5.20

2.7

3.1

8.22

5.05

e9/l

1.01

161

1154

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

127

2.46

5.12

1.3

1.5

—

(3011985) Renin [Units/volume] in Plasma

278

1.96

5.12

1.5

1.4

65.28

44.71

mu/l

0.32

249

(3012441) Differential panel - Pleural fluid

210

2.11

5.12

1.4

—

(40761536) Microorganisms panel - Urine sediment

238

1766

1.38

5.09

6.0

3.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

158

1088

1.48

5.08

2.6

2.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

140

2.37

5.07

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

4.47

5.05

1.4

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.18

5.04

1.5

1.2

35.59

37.42

g/l

—

(3013512) EKG study

715

6135

1.23

5.03

4.3

3.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

531

1.68

4.99

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

129

2.42

4.97

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

123

2.46

4.96

1.2

1.3

1.34

1.20

nmol/l

0.28

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.67

4.92

1.1

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

124

1836

0.66

4.91

1.8

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

174

2.20

4.91

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

304

1.89

4.89

3.2

2.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

106

2.56

4.88

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

106

2.56

4.88

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

149

2.30

4.87

1.7

1.4

1.21

1.35

promille

0.19

115

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

591

1.63

4.81

2.1

2.7

3.83

3.61

g/l

0.81

561

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

438

1.73

4.80

1.7

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

230

2.02

4.76

1.5

1.4

40107.55

96077.87

e6/l

0.81

134

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

265

1.94

4.74

1.8

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

190

2.12

4.73

1.2

1.3

1.50

1.36

nmol/l

0.38

170

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

503

1.67

4.66

1.8

1.9

2.70

4.55

iu/l

2.40

170

(3022313) Gas panel - Capillary blood

134

910

1.50

4.64

5.5

3.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

172

2.17

4.62

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.81

4.55

1.1

1806.33

1512.65

miu/ml

0.61

(3044007) Cell count panel - Peritoneal fluid

3.07

4.51

1.6

2.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

284

1.88

4.51

1.1

1.50

1.51

g/l

0.06

256

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

148

2.25

4.50

1.3

1.2

0.98

0.66

u/ml

0.23

(44816559) Phosphatidylethanol [Mass/volume] in Blood

357

1.78

4.49

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

174

1252

1.42

4.47

1.4

1.3

66.44

53.27

au/ml

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

329

1.81

4.44

1.5

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.94

4.44

3.7

2.2

257.14

38391.08

u/ml

—

(3036489) Thrombin time

116

772

1.53

4.43

1.7

2.1

21.08

21.49

0.35

108

677

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

182

2.10

4.42

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

209

2.03

4.42

7.0

5.8

7.99

7.32

mmol/l

0.51

173

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.70

4.41

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.70

4.41

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.70

4.41

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

233

1764

1.35

4.41

2.2

1.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

176

2.12

4.38

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

203

2.04

4.38

3.5

2.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

189

1388

1.39

4.33

2.6

2.4

28.73

23.23

au/ml

—

103

(3003434) Protein [Mass/volume] in Pleural fluid

274

1.88

4.32

1.5

1.4

30.72

32.59

g/l

0.43

242

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.66

4.32

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.66

4.32

1.3

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.66

4.32

1.2

8.1

50.63

65.68

mg/l

0.79

(21494890) Protein electrophoresis panel - 24 hour Urine

205

2.02

4.27

1.4

2.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.50

4.24

1.6

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

455

1.67

4.22

1.7

1.3

14.13

10.39

u/l

1.12

370

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

262

1.89

4.22

1.9

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

510

1.63

4.20

1.2

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

187

1379

1.38

4.18

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

264

1.87

4.13

1.9

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.35

4.12

5.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

4.35

4.12

3.1

3.0

—

12.60

—

(3039000) Anion gap in Blood

466

1.65

4.12

6.6

6.5

11.85

11.25

mmol/l

0.87

408

(3004716) Salmonella sp identified in Stool by Organism specific culture

141

992

1.45

4.12

1.6

1.3

—

(3018572) Chloride [Moles/volume] in Blood

467

1.65

4.09

6.6

6.5

103.92

105.32

mmol/l

1.53

409

(44813793) Dust mix specific IgE antibody measurement

112

2.33

3.92

1.1

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

106

2.37

3.90

1.2

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

115

788

1.48

3.86

1.4

31.75

32.13

iu/l

0.04

102

671

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

109

739

1.50

3.86

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

256

1.85

3.85

1.9

1.4

—

(3033799) Differential panel - Peritoneal fluid

2.78

3.85

1.5

2.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

264

1.83

3.82

1.6

1.4

2549.67

1882.22

e6/l

0.31

192

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

257

1.84

3.81

1.9

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

3.70

3.79

1.1

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

2.85

3.79

2.4

2.2

30.71

29.50

0.12

(3005988) Vibrio sp identified in Specimen by Organism specific culture

258

1.84

3.77

1.9

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

108

2.33

3.76

1.2

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

208

1588

1.34

3.75

2.1

1.8

—

(21494755) Public health laboratory ask at order entry panel

138

1898

0.71

3.72

1.3

1.4

—

(3019225) pH of Specimen

266

2106

1.29

3.70

5.4

4.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

155

2.08

3.67

1.2

193.33

129.09

titre

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

261

1.82

3.64

1.4

393.85

322.07

pmol/l

0.57

225

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.54

3.63

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1222

0.65

3.57

1.5

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

112

777

1.46

3.56

5.6

3.8

24.73

24.96

mmol/l

0.31

101

725

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

2.51

3.54

2.2

1.6

26.12

29.89

umol/l

1.07

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

228

1.86

3.51

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

228

1.86

3.51

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

158

2.04

3.50

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

10.02

3.49

1.0

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

186

1.95

3.48

1.5

1.4

—

(3016750) Collection duration of Urine

132

2.13

3.45

2.3

2.1

512.63

485.70

min

0.56

(3039443) Prostate specific Ag panel - Serum or Plasma

405

0.42

3.43

1.3

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

146

2.07

3.42

1.3

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

209

1.88

3.40

2.9

3.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.55

3.29

1.1

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

505

1.54

3.23

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.34

3.22

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.59

3.21

1.6

2.2

134218.89

2145.65

e6/l

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.87

3.19

1.6

2.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

104

2.22

3.15

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.74

3.15

1.1

1.6

14.89

12.26

g/l

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

552

1.50

3.07

1.2

1.3

203.03

210.44

miu/ml

0.06

252

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

132

2.06

3.06

2.4

2.0

15.78

15.66

0.02

126

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

322

1.66

3.06

1.2

1.1

—

(3003338) MCHC [Mass/volume]

1867

17855

1.17

3.04

29.4

17.6

331.30

332.23

g/l

4.23

1858

17722

(3051651) Icteric interference index of Serum or Plasma

119

2.11

3.04

3.3

3.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.56

2.99

7.8

7.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

10.02

2.98

3.8

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

296

1.67

2.91

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.22

2.89

2.0

3.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.38

2.89

2.6

2.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.38

2.89

1.6

2.5

8256.23

783.18

e6/l

0.44

(3045788) Cell count panel - Pleural fluid

207

1.80

2.87

1.6

1.4

—

(40768806) Pleura Pathology biopsy report

215

1.78

2.84

1.7

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

291

1.66

2.82

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

238

1.73

2.81

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

564

1.47

2.79

1.9

1.5

304.65

294.60

mu/l

0.10

509

(3009871) Measles virus Ab [Titer] in Serum

2.55

2.78

1.5

1.7

—

(3006245) CD3-CD19+ cells/100 cells in Blood

2.55

2.78

2.5

2.2

12.53

11.12

0.21

(3032057) Clostridioides difficile [Presence] in Stool

3.09

2.77

1.8

2.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

5.01

2.73

1.7

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.24

2.70

4.4

4.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

311

2605

1.22

2.70

10.4

6.6

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.01

2.70

7.3

5.1

446.17

384.60

umol/l

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.29

2.67

1.3

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.29

2.67

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.76

2.67

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.76

2.67

1.8

1.7

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.76

2.67

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.76

2.67

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.76

2.67

1.2

1.1

93.22

95.58

—

(40768441) Liver Pathology biopsy report

147

1.91

2.65

1.0

1.4

—

(3004775) Volume in Urine collected for unspecified duration

176

1.83

2.64

2.3

2.2

671.14

613.13

0.31

119

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.47

2.62

1.1

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

113

2.04

2.61

2.2

—

(3006653) Thiamine [Moles/volume] in Blood

120

2.01

2.60

1.2

138.50

137.22

nmol/l

0.04

120

(1761868) Lipid panel - Serum or Plasma

680

7528

0.87

2.56

3.2

2.8

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

7.15

2.55

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

7.15

2.55

1.0

—

(4035726) Immunohistochemistry procedure

226

1848

1.24

2.47

1.5

1.4

—

(3004451) EKG impression Narrative

102

2.07

2.47

1.9

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

266

1.63

2.38

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

338

1.55

2.35

1.4

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

706

1.37

2.31

2.5

1.8

—

(3011288) Drugs identified in Urine by Screen method

388

1.51

2.31

2.0

2.8

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.95

2.28

1.5

110.97

116.54

ng/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.90

2.25

1.6

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

157

1.79

2.21

1.1

1.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

5.56

2.21

1.4

29.30

19.02

mg/l

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.56

2.21

94.2

4.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

100

2.01

2.20

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

100

2.01

2.20

1.3

1.7

—

(3013637) Mi-2 Ab [Presence] in Serum

2.69

2.20

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.69

2.20

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.69

2.20

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.69

2.20

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

210

1.68

2.20

3.3

3.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

257

1.60

2.18

1.6

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

4.29

2.15

1.3

1.1

0.04

0.01

u/ml

—

(3001729) Color of Synovial fluid

3.69

2.15

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.30

2.14

1.6

1.3

50.64

178.59

nmol/24h

0.65

(3017446) Testosterone [Moles/volume] in Serum or Plasma

177

1434

1.25

2.13

2.5

2.2

11.90

12.74

nmol/l

0.69

156

1279

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

243

1.61

2.13

1.3

35.34

29.99

u/l

0.42

198

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.37

2.12

1.3

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

145

1.80

2.10

1.3

1.4

10.40

9.35

mmol/l

0.41

138

(3008037) Lactate [Moles/volume] in Venous blood

456

1.44

2.08

3.0

1.41

1.56

mmol/l

1.14

442

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

206

1.66

2.07

2.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.01

2.07

1.2

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

3.08

2.01

1.0

1.3

—

mmol/l

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

104

1.93

2.00

1.2

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

352

1.49

2.00

1.1

17.07

1577.96

iu/ml

0.53

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.29

1.97

1.2

0.37

0.29

g/l

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

305

1.52

1.95

1.4

1.2

3.13

5.31

u/ml

1.05

130

(3008536) Aspergillus sp Ab [Presence] in Serum

2.57

1.94

2.4

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

127

1.82

1.94

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.97

1.93

1.5

1.3

—

(3049717) Cytology report of Urine Cyto stain

103

791

1.31

1.92

2.3

2.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

406

1.44

1.90

3.7

3.2

0.94

0.81

nmol/l

0.53

315

(3043238) Trisomy 21 risk [Likelihood] in Fetus

265

0.49

1.87

1.1

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.21

1.84

1.3

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.21

1.84

2.2

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

126

1005

1.27

1.78

1.1

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

260

0.50

1.78

1.2

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

146

1.72

1.77

3.8

2.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

177

1.65

1.76

1.2

1.1

—

u/ml

—

(3005033) Fetal Nuchal fold Thickness US

258

0.50

1.74

1.1

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

482

1.38

1.73

2.7

2.1

11405.53

3549.97

u/l

0.53

201

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.85

1.71

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

332

1.45

1.70

1.4

1.2

23.15

40.42

u/l

1.11

283

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

118

1.79

1.70

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

118

1.79

1.70

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

141

1.71

1.68

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.44

1.64

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.25

1.63

1.4

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

114

910

1.26

1.62

2.4

1.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

311

1.45

1.61

1.4

1.2

4.72

4.04

u/ml

0.10

106

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

506

1.35

1.61

1.5

1.2

666.58

508.43

mg/l

0.67

481

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

159

1.64

1.59

1.3

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.00

1.58

2.2

3.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.70

1.58

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

144

1.67

1.57

1.8

1.5

78.67

84.17

umol/l

0.37

144

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.21

1.57

1.3

1.5

31.63

25.44

g/l

—

(40757373) Influenza virus identified in Isolate

2.28

1.55

1.7

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

122

1.73

1.54

2.6

2.7

36.40

41.22

0.73

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

200

1.56

1.54

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

2.43

1.53

3.5

6.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.83

1.51

1.4

1.5

—

(40758292) HTLV I+II Ab panel - Serum

2.60

1.51

1.3

—

(3024263) Appearance of Synovial fluid

108

1.76

1.50

1.1

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.87

1.50

2.9

2.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.95

1.48

1.1

1.0

—

(3035880) pH of Pleural fluid

117

1.71

1.45

1.5

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.92

1.43

2.3

1.6

1.79

2.01

umol/l

1.03

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

315

0.60

1.43

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

315

0.60

1.43

1.1

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

339

0.62

1.42

1.1

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

313

0.60

1.40

1.1

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

313

0.60

1.40

1.1

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.20

1.37

1.4

1.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.61

1.36

1.2

—

640.53

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.61

1.36

1.5

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

522

1.31

1.35

4.2

4.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

232

1.47

1.34

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

105

1.72

1.33

2.1

2.5

—

(3038515) Glucose [Moles/volume] in Venous blood

429

1.34

1.30

3.1

7.40

7.57

mmol/l

0.21

416

(3022621) pH of Urine by Test strip

163

1392

1.18

1.26

3.3

2.9

—

(3044290) Cell count panel - Cerebral spinal fluid

406

1.34

1.25

1.5

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

101

1.69

1.19

1.2

1.1

—

13.80

u/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

463

1.30

1.18

3.8

3.6

25.99

26.62

mg/l

0.05

290

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.05

1.15

1.4

3.4

—

(3028717) Thiamine [Mass/volume] in Blood

2.50

1.15

1.0

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.50

1.15

1.4

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

249

2216

1.14

1.13

2.8

4.1

4.90

20.41

ug/l

3.12

208

1807

(3048879) Bone marrow aspiration report

1.90

1.12

1.1

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1061

0.81

1.11

1.9

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.78

1.10

2.5

2.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

593

1.26

1.10

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.95

1.08

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

121

1.57

1.05

1.0

1.1

—

10.49

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

123

0.49

1.05

1.2

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

254

1.38

1.04

1.8

2.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

383

0.70

1.04

4.4

3.8

34.96

31.84

u/ml

0.12

372

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.89

1.01

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

440

1.28

1.00

1.6

1.3

5724.70

1003.09

e6/l

0.48

359

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

440

1.28

1.00

1.5

1.3

78.12

20.52

e6/l

0.45

341

(3025018) Bordetella pertussis Ab [Titer] in Serum

115

1.57

0.99

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

300

1.34

0.99

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.18

0.98

1.0

1.2

—

(3014271) Vancomycin [Susceptibility]

1.63

0.97

3.3

2.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.86

0.96

1.0

1.1

97.40

86.29

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.86

0.96

1.0

95.20

87.89

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.86

0.96

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.77

0.94

1.1

1.2

15.29

17.07

umol/l

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.77

0.94

1.2

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.72

0.92

1.3

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

682

6456

1.08

0.92

4.6

4.8

2.19

2.80

ug/l

1.16

610

5787

(3003740) Influenza virus B Ag [Presence] in Specimen

289

1.32

0.88

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

290

1.32

0.86

5.0

5.3

319.62

362.50

umol/l

0.77

254

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.82

0.85

5.6

2.4

—

(3027944) Amphetamines [Presence] in Urine

568

1.22

0.85

1.8

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.67

0.85

1.0

—

(3036180) Methadone [Presence] in Urine

1.67

0.85

1.6

1.8

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

112

1.52

0.84

2.9

1.7

0.91

2.17

u/field

1.77

(3002523) Influenza virus A Ag [Presence] in Specimen

291

1.31

0.84

1.1

—

(3022689) Creatine [Moles/volume] in Urine

1.76

0.83

1.3

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

141

0.57

0.82

1.0

1.3

1.53

1.57

g/l

—

141

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

350

3774

0.92

0.82

2.8

3.0

0.66

0.75

ug/l

1.17

239

2467

(3016879) Cocaine [Presence] in Urine

526

1.22

0.81

1.8

2.2

—

(3028300) Cannabinoids [Presence] in Urine

581

1.21

0.81

1.8

2.1

—

(3002256) Pathology report gross observation

299

2751

1.10

0.80

1.3

—

(40768800) Prostate Pathology biopsy report

397

0.75

0.80

1.3

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

546

1.21

0.79

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

345

3198

1.09

0.79

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

321

1.28

0.79

1.2

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

139

1.44

0.79

1.3

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

574

1.21

0.79

1.8

2.1

—

(3003694) ABO and Rh group [Type] in Blood

604

5726

1.07

0.79

1.4

—

(3045424) Erythrocytes [Presence] in Urine

348

1.27

0.78

1.6

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

173

1.39

0.78

2.5

2.1

1.00

2.20

u/field

1.02

(21494814) CD8 cells/100 lymphocytes in Specimen

1.62

0.78

2.2

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

630

1.20

0.78

1.4

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

126

0.55

0.77

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

115

1.48

0.76

1.1

0.90

1.13

u/l

—

(3027008) Opiates [Presence] in Urine

577

1.20

0.75

1.8

2.1

—

(3047189) Immunofixation for 24 hour Urine

1.52

0.75

1.2

1.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

133

1.43

0.73

1.5

2.0

—

(1002224) Polysomnography panel

840

1.16

0.72

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.58

0.71

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.92

0.70

4.2

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

565

0.81

0.70

1.2

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

193

0.67

0.69

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.53

0.68

1.1

—

(40765096) Chromosome analysis panel by Banding

1.53

0.68

1.4

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

119

1.43

0.67

1.2

1.1

1.01

1.04

ratio

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

137

1.39

0.64

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

451

1.20

0.63

2.0

2.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

104

0.58

0.62

1.0

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.67

0.61

3.0

2.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.67

0.61

1.0

1.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.60

0.0

2.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.54

0.59

1.1

—

(40768795) Lymph node Pathology biopsy report

201

1.30

0.59

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

114

1.41

0.58

13.1

11.8

905.94

847.15

nmol/l

0.24

109

(3014051) Protein [Presence] in Urine by Test strip

573

0.83

0.58

2.2

2.3

—

(3045142) Bone marrow Pathology biopsy report

228

1.28

0.58

1.2

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.46

0.58

1.0

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

447

1.19

0.57

2.2

3.3

59.55

965.20

u/ml

0.93

413

(3005570) Glucose [Moles/volume] in Urine

221

1.27

0.55

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

266

1.24

0.55

2.8

2.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.58

0.54

1.2

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.50

0.54

1.4

2.88

2.95

mmol/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.50

0.54

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.48

0.53

1.1

—

(3015183) Erythrocyte sedimentation rate

0.61

0.52

1.0

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

109

1.38

0.51

1.5

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.46

0.50

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

155

0.71

0.48

2.0

1.5

1.27

4.93

ug/l

—

132

(3016018) Differential panel - Cerebral spinal fluid

209

1.25

0.46

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

275

2595

1.07

0.45

4.5

31.06

32.42

1.33

199

1742

(3050129) First trimester maternal screen panel - Serum or Plasma

363

0.82

0.45

1.2

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

112

1.34

0.44

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

148

1.29

0.43

1.2

1.1

31.14

41.35

mg/l

0.87

123

(3000034) Microalbumin [Mass/volume] in Urine

193

1.25

0.43

3.2

2.9

63.74

29.60

mg/l

0.27

139

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.61

0.43

1.2

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

248

1.21

0.43

1.9

1.5

0.16

0.29

nmol/l

1.94

187

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

276

1.20

0.42

1.4

1.2

—

nmol/l

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

122

1.31

0.42

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.38

0.41

5.0

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.38

0.41

5.0

2.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.52

0.41

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.47

0.40

1.6

1.3

73.34

94.66

ng/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.43

0.39

1.4

1.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

301

1.17

0.35

1.1

—

9.61

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.36

0.34

1.0

1.1

—

(40768793) Breast Pathology biopsy report

510

0.88

0.34

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.31

0.33

1.8

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

1.27

0.31

1.2

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

110

1.27

0.31

2.5

2.1

10.00

209.86

ug/min

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

258

1.16

0.31

2.1

2.3

30.98

23.69

mg/l

0.41

(3020650) Glucose [Presence] in Urine

1.27

0.30

1.3

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.29

0.30

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

194

1.19

0.29

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

250

1.16

0.29

1.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

533

5185

1.04

0.29

4.4

4.2

21.32

21.73

0.25

232

2484

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

689

1.09

0.28

2.1

1.9

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.32

0.28

1.2

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

140

1.22

0.27

1.2

1.5

162.45

230.77

pmol/l

0.46

140

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

113

1.24

0.26

1.6

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

281

1.14

0.26

1.4

1.3

—

(21494434) Karyotype in Bone marrow

179

1.17

0.25

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.25

0.24

1.1

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

677

1.08

0.24

1.3

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.28

0.23

2.0

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

125

1.20

0.22

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.74

0.22

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

778

1.07

0.21

2.7

3.5

150.91

4108.24

u/ml

0.62

658

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

29.20

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

108

1.20

0.20

1.2

1.4

6.17

6.05

mmol/l

0.10

102

(3035933) Granulocytes/100 leukocytes in Blood

1.23

0.20

1.2

1.4

—

(3003129) Base excess in Capillary blood by calculation

1.20

0.19

2.7

1.3

-0.78

1.14

mmol/l

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.19

0.18

1.4

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.19

0.18

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

746

1.06

0.18

1.7

12.10

3.53

mg/l

0.64

543

(3043410) Blood group antigens tested for on Red Blood Cells

1.13

0.17

3.0

2.0

—

(4034850) Laboratory test

679

1.06

0.17

9.2

9.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.11

0.17

1.7

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

196

1.12

0.16

1.2

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

102

1.18

0.15

26.0

12.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

188

1.12

0.14

1.2

—

(3023410) Appearance of Cerebral spinal fluid

198

1.11

0.14

1.4

—

(4146454) Self-monitoring of blood glucose

238

1.09

0.13

2.7

2.6

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

109

0.83

0.13

6.7

11.2

0.67

0.63

mmol/l

—

104

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

271

0.92

0.11

1.4

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

202

1.09

0.10

1.5

—

(3045414) Leukocytes [Presence] in Urine

959

1.03

0.10

1.7

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.09

0.09

1.0

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

186

0.91

0.09

1.2

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

236

0.93

0.08

1.8

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.84

0.07

1.2

1.1

—

(3034426) Prothrombin time (PT)

0.84

0.07

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.03

0.07

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

175

1723

1.02

0.06

1.4

1.3

—

(3000330) Specific gravity of Urine by Test strip

109

1069

1.02

0.05

3.8

3.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

111

1128

0.98

0.04

2.8

3.4

36.28

60.28

u/ml

1.41

105

1089

(4281824) Cell count and differential, peritoneal fluid

241

0.95

0.04

1.1

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

163

1.04

0.01

1.5

0.91

0.98

g/l

0.48

163

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

106

0.94

0.01

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

355

0.99

0.00

1.9

1.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

201

0.99

0.00

3.8

5.0

259.52

39.99

u/ml

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

138

1.01

0.00

5.4

6.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

14.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.96

-0.00

1.4

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.13

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.95

-0.00

1.7

2.9

210.56

202.47

u/l

—

(3006462) Nitrate [Presence] in Urine

0.92

-0.00

3.7

3.1

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

5.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

3.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

253.67

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

2553.32

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

330.83

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

3.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_LICHSIMPANDPRURIGO and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_LICHSIMPANDPRURIGO	1.42 [1.28, 1.58]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.288

During the follow-up period (1.1.1998 — 31.12.2019), 1395 out of 7396 females with L12_LICHSIMPANDPRURIGO died.

Males

Parameter	HR [95% CI]	p-value
L12_LICHSIMPANDPRURIGO	1.511 [1.36, 1.68]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.018

During the follow-up period (1.1.1998 — 31.12.2019), 1474 out of 6002 males with L12_LICHSIMPANDPRURIGO died.

Mortality risk

Mortality risk for people of age

years, who have L12_LICHSIMPANDPRURIGO.

N-year risk	Females	Males
1	0.126%	0.335%
5	0.773%	1.944%
10	1.863%	4.649%
15	3.905%	8.447%
20	7.104%	14.341%

Relationships between endpoints

↥

Index endpoint: L12_LICHSIMPANDPRURIGO – Lichen simplex chronicus and prurigo

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Lichen simplex chronicus and prurigo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints